Dimethylnitrosamine - Induced Neoplasms in F344 Male Rats With Various Manipulations of the Mixed-Function-Oxidase System: Macroscopic, Microscopic, Ultrastructural, and Immunocytochemical Evaluation. by Gliatto, John Michael
Louisiana State University
LSU Digital Commons
LSU Historical Dissertations and Theses Graduate School
1987
Dimethylnitrosamine - Induced Neoplasms in





Louisiana State University and Agricultural & Mechanical College
Follow this and additional works at: https://digitalcommons.lsu.edu/gradschool_disstheses
This Dissertation is brought to you for free and open access by the Graduate School at LSU Digital Commons. It has been accepted for inclusion in
LSU Historical Dissertations and Theses by an authorized administrator of LSU Digital Commons. For more information, please contact
gradetd@lsu.edu.
Recommended Citation
Gliatto, John Michael, "Dimethylnitrosamine - Induced Neoplasms in F344 Male Rats With Various Manipulations of the Mixed-
Function-Oxidase System: Macroscopic, Microscopic, Ultrastructural, and Immunocytochemical Evaluation." (1987). LSU Historical
Dissertations and Theses. 4356.
https://digitalcommons.lsu.edu/gradschool_disstheses/4356
INFORMATION TO USERS
While the most advanced technology has been used to 
photograph and reproduce this manuscript, the quality of 
the reproduction is heavily dependent upon the quality of 
the material submitted. For example:
•  Manuscript pages may have indistinct print. In such 
cases, the best available copy has been filmed.
•  Manuscripts may not always be complete. In such 
cases, a note will indicate that it is not possible to 
obtain missing pages.
•  Copyrighted material may have been removed from 
the manuscript. In such cases, a note will indicate the 
deletion.
Oversize materials (e.g., maps, drawings, and charts) are 
photographed by sectioning the original, beginning at the 
upper left-hand corner and continuing from left to right in 
equal sections with small overlaps. Each oversize page is 
also filmed as one exposure and is available, for an 
additional charge, as a standard 35mm slide or as a 17”x 23” 
black and white photographic print.
Most photographs reproduce acceptably on positive 
microfilm or microfiche but lack the clarity on xerographic 
copies made from the microfilm. For an additional charge, 
35mm slides of 6”x 9” black and white photographic prints 
are available for any photographs or illustrations that 
cannot be reproduced satisfactorily by xerography.
8 7 1 9 8 6 4
DIMETHYLNITROSAMINE-INDUCED NEOPLASMS IN F344 MALE RATS 
WITH VARIOUS MANIPULATIONS OF THE MIXED-FUNCTION-OXIDASE 
SYSTEM: MACROSCOPIC, MICROSCOPIC, ULTRASTRUCTURAL, AND
IMMUNOCYTOCHEMICAL EVALUATION
Gliatto, John Michael, Ph.D.
The Louisiana State University and Agricultural and Mechanical Col., 1987
UMI
300 N. Zeeb Rd.
Ann Arbor, MI 48106
PLEASE NOTE:
In all cases this material has been filmed in the best possible way from the available copy. 
Problems encountered with this docum ent have been identified here with a  check mark V_
1. Glossy photographs or p a g es .
2. Colored illustrations, paper or print [S'
3. Photographs with dark background
4. Illustrations are poor copy______
5. Pages with black marks, not original copy
6. Print shows through as there is text on both sides of page_
7. Indistinct, broken or small print on several pages
8. Print exceeds margin requirem ents______
9. Tightly bound copy with print lost in sp ine_______
10. Computer printout pages with indistinct print.
11. Page(s)_____________lacking when material received, and  not available from school or
author.
12. Page(s)_____________seem to be missing in numbering only as text follows.
13. Two pages num bered  . Text follows.
14. Curling and wrinkled p ag es______





DIMETHYLNITROSAMINE-INDUCED NEOPLASMS IN F344 MALE RATS 
WITH VARIOUS MANIPULATIONS OF THE MIXED-FUNCTION-OXIDASE 
SYSTEM: MACROSCOPIC, MICROSCOPIC, ULTRASTRUCTURAL, AND 
IMMUNOCYTOCHEMICAL EVALUATION
A Dissertation
Submitted to the Graduate Faculty of the 
Louisiana State University and 
Agricultural and Mechanical College 
in partial fulfillment of the 
requirements for the degree of 
Doctor of Philosophy
in
The Interdepartmental Program 
in Veterinary Medical Sciences
by
John Michael Gliatto 
B.S., University of Delaware, 1977 
V.M.D., University of Pennsylvania, 1981 
May, 1987
ACKNOWLEDGEMENTS 
"No kid does it on their own, mama."
With this immortal line uttered by Natalie Wood to 
Rosalind Russel in the film version of the Broadway musi­
cal hit, "Gypsy", I begin my long list of indebtedness. 
Not that becoming a famous striptease artist and earning 
a Ph.D. are necessarily comparable, but there are simi­
larities in that along both routes there are a number of 
people that contribute to the process; it is never the 
single effort of one individual.
Therefore, I would first like to extend special 
thanks to my committee members: Drs. H. Wayne Taylor, 
Harold W. Casey, Stephen D. Gaunt, E. D, Roberts, and 
Wayne Flory. I am grateful to Dr. Taylor for heading 
the committee and providing some of the original ideas 
for this dissertation project. I also would like to 
thank Dr. Flory for providing the procedure for the 
0 - d e m e t h y 1 ase assay, which was a modification of a 
previous graduate student’s modification of Dr, Charles 
Short's dissertation procedure. Each committee member 
has offered sound advice at some point or another during 
this ordeal. Thanks also to Drs. James Turk and Lawrence 
Ruhr, who were original committee members but later 
bolted.
In the technical category, I would like to thank
Cheryl Crowder for the use of her lab, her materials, and 
her technical ad v i c e  and expertise; as well as for the 
processing and sectioning of most of my tissue sections. 
Assisting her were the able hands of Del Phillips, Diana 
Grandt, and C.A. Green.
I am especially grateful to Andrea Smith for the pro­
cessing and thin sectioning of tissue for TEM analysis, 
and for the novenas to St. Jude Thaddeus on my behalf.
Thanks is extended to Lynn Montgomery for expedi­
ting the ordering process of much-needed materials on 
several occasions. Thanks also to Billie Cleghorn for 
use of various materials in her lab.
Statistical evaluation was provided by Dr. James 
Geaghan of the Department of Experimental Statistics, 
and I thank him for his efforts on my behalf.
Numerous individuals were helpful in the photogra­
phic department including Mary Bowen, Dr. Clay Hodgin,
Dr. Ron Snider and Dr. Bill Henk.
I would also like to thank Dr. Mark Simpson for pro­
viding a copy of Dr. Pauline Rakich's immunoperoxidase 
staining techniques, which greatly aided in 'stilling the 
turbulent waters of my soul'(St. Bettina Albigianari, pa­
tron saint of grocery clerks). In addition, thank you to 
Dr. John Kreeger, whose extensive computerial skills res­
cued a large portion of this manuscript, believed to be
iii
lost in the abysmal recesses of the computer's brain.
Many people are left unmentioned, but through small 
acts of kindness, profferings of sound advice, or re­
commendation of a decent analyst deserve some sort of 
recognition. Let me just say, they know who they are,





Table of Contents................................................. v




Chapter I: Literature Review..... ............................. 1
Chapter II: DMN-Induced Hepatic, Renal, and
Pulmonary Neoplasms in Male Fischer 
344 Rats with Various Manipulations 
of the Mixed-Function-Oxidase Sys­






Chapter III: Examination of the Effects of Various 
Manipulations of the Mixed-Function- 
Oxidase System in Male F344 Rats on 
Hepatic O-demethylase Activity as
Measured by the P-Nitroanisole Assay.......126
Introduction.....................................127
Materials and Methods......................... 129
Results.........   134
Discussion....................................... 136
Chapter IV: Characterization of Dimethylnitrosamine- 
Induced Hepatic, Renal, and Pulmonary 






Chapter V: Summary and Conclusions........................ 179
v
TABLE OF CONTENTS (continued)
Bibliography.................................................... 183





Table I: Tumor numbers, liver................................39
Table II: Hepatocytic tumors, statistics................... 40
Table III: HES, statistics.................................... 40
Table IV: Tumor numbers, kidney......................... .,,.52
Table V: Proximal tubular tumors, statistics.............. 53
Table VI: R M T , statistics.................................... .53
Table VII: Tumor numbers, lung............................... 54
Table VIII: Pulmonary epithelial tumors, statistics 55
Table IX: Liver/body weights................................ 113
Table X: Liver/body weights, statistics................... 113
Table XI: Water consumption..................................114
Table XII: Water consumption, statistics..................114
Table XIII: Enzyme activities.......   136





Figure 1: Hepatic cell dysplasia(LM)..................... 35
Figure 2: CARC, liver, 4 weeks(TEM)......   35
Figure 3: CARC-PH, liver, 4 weeks(TEM).................. 42
Figure 4: Altered focus(LM)................................ 42
Figure 5: Neoplastic nodule(LM)........................... 45
Figure 6: Altered tubule, kidney(LM)..................... 45
Figure 7: Alveolar cell hyperplasia(LM)................. 47
Figure 8: CARC-AAN, liver, 12 w e e k s ( T E M 47
Figure 9: CARC-eth, liver, 12 weeks(TEM)................ 51
Figure 10: Neoplastic nodules, liver(Gross)..............51
Figure 11: Cortical adenoma, kidney(Gross)...............57
Figure 12: Cystic cholangioma(LM).......................... 60
Figure 13: Cholangiofibrosis(LM ) ........................... 60
Figure 14: Adenoma, kidney(LM)..............................64
Figure 15: Alveolar/bronchiolar adenoma(LM)..............64
Figure 16: Alveolar/bronchiolar carcinoma (LM)........... 65
Figure 17: Alveolar/bronchiolar carcinoma(LM)........... 65
Figure 18: CARC-PB, liver, 24 weeks(TEM)................. 66
Figure 19: CARC-PB, liver, 24 weeks(TEM)................. 67
Figure 20: CARC-AAN, liver, 24 weeks(TEM)................ 68
Figure 21: CARC-AAN, liver, 24 weeks(TEM)................ 69
Figure 22: Nodular liver(Gross)............................ 72
Figure 23: Nodular liver(Gross)............................ 72
viii
LIST OF FIGURES (continued)
Figure 24: Hemangioendothelial sarcoma(Gross)........... 74
Figure 25: Renal adenocarcinoma(Gross)....................74
Figure 26: Renal mesenchymal tumor(Gross)................. 76
Figure 27: Renal mesenchymal tumor(Gross)................. 76
Figure 28: Alveolar/bronchiolar carcinoma(Gross)....... 78
Figure 29: Hemangioendothelial sarcoma(LM)...............83
Figure 30: Renal adenocarcinoma(LM)....................... 83
Figure 31: Renal mesenchymal tumor(LM)..................... 85
Figure 32: Renal mesenchymal tumor(LM)..................... 85
Figure 33: Hemangioendothelial sarcoma, lung(LM)........ 88
Figure 34: CARC, liver, 36 weeks(TEM)...................... 90
Figure 35: CARC, liver, 36 weeks(TEM)...................... 91
Figure 36: CARC, liver, 36 weeks(TEM)...................... 92
Figure 37: CARC, liver, 36 weeks(TEM)......................93
Figure 38: CARC, liver, 36 weeks(TEM)...................... 93
Figure 39: CARC-PH, liver, 36 weeks(TEM) ......,,..94
Figure 40: CARC-PH, liver, 36 weeks(TEM).................. 94
Figure 41: CARC-PH, liver, 36 weeks(TEM).........  95
Figure 42: CONT-PB, liver, 36 weeks(TEM).................. 97
Figure 43: CARC, liver, 36 weeks(TEM)...................... 98
Figure 44: Hemangioendothelial sarcoma(TEM)..............100
Figure 45: Hemangioendothelial sarcoma(TEM)..............100
Figure 46: Hemangioendothelial sarcoma(TEM)..............101
Figure 47: Hemangioendothelial sarcoma(TEM)..............102
ix
LIST OF FIGURES (continued)
Figure 48: Renal adenocarcinoma(TEM)................ ,,,,104
Figure 49: Renal adenocarcinoma(TEM)..................... 104
Figure 50: Renal adenocarcinoma(TEM)..................... 105
Figure 51: Renal adenocarcinoma(TEM)..................... 106
Figure 52: Renal adenocarcinoma(TEM) . . . ,  ............... 107
Figure 53: Renal mesenchymal tumor(TEM)..................109
Figure 54: Renal mesenchymal tumor (•TEM)................ 110
Figure 55: Renal mesenchymal tumor(TEM)................. Ill
Figure 56: Alveolar cell hyperplasia(TEM)............... 115
Figure 57: Alveolar cell hyperplasia(TEM)............... 115
Figure 58: Alveolar/bronchiolar carcinoma(TEM).........116
Figure 59: Alveolar/bronchiolar carcinoma(TEM)......... 116
Figure 60: Alveolar/bronchiolar carcinoma(TEM).........117
Chapter IV
Figure 1: Vimentin, HES, liver(LM)...................... 154
Figure 2: Vimentin, HES, lung(LM)........................154
Figure 3: Factor VIII-RA, HES, lung(LM)................ 156
Figure 4: Desmin, HES, liver(LM).........................156
Figure 5: Cytokeratin, RAC(LM)........................... 159
Figure 6: Vimentin, RAC(LM)............................... 159
Figure 7: Cytokeratin, RMT(LM)...................... ,...161
Figure 8: Factor VIII-RA, RMT(LM)....................... 161
Figure 9: Vimentin, RMT(LM).........  163
x
LIST OF FIGURES (continued)
Figure 10: Vimentin, RMT(LM)...............................163
Figure 11: Factor VIII-RA, RMT(LM)....................... 165
Figure 12: Cytokeratin, RMT(LM)........................... 165
Figure 13: Cytokeratin, cholangiofibrosis, l i v e r ( L M ) 167
ABSTRACT
Aminopyrine and nitrite were administered to male 
F344 rats at concentrations of lmg each per ml drinking 
water as precursors of dimethylnitrosamine (DMN). Rats 
were divided into groups based on manipulations of the 
mixed-function-oxidase (MFO) system including: partial 
hepatectomy, subcutaneous injections of aminoacetonitrile 
(AAN), phenobarbital (plus 1.75% ethanol) and 1.75% 
ethanol.
Rats were k i l l e d  at 4 weeks, 12 weeks, 24 weeks, 
and 36 weeks following initiation of the carcinogenic re­
gimen. DMN-induced neoplasms occurred in three target or­
gans; namely, the liver, kidneys, and lungs. The number 
and types of tumors, as w e l l  as the target organ affected 
often depended on the particular MFO system manipulation. 
The most striking effect of this nature was the 
hepatoprotective action of both phenobarbital and 
ethanol.
By macroscopic, microscopic, and ultrastructural 
evaluation, DMN-induced tumors included those derived from 
both hepatocytic and bile duct epithelium in the liver, 
endothelial cells within the liver, proximal convoluted 
epithelium and the interstitial cortical fibrocyte in the 
kidney, and exclusively from the type II pneumocyte within 
the lung.
xii
A metabolic study on the specific" activity of hepatic 
O-demethylase, a P-450 dependent microsomal enzyme, from 
frozen liver samples of sacrificed animals over the course 
of the experiment, revealed that this enzyme was generally 
induced by phenobarbital and ethanol, quite in accordance 
with the behavior of many microsomal enzyme systems. Al­
though the specific activity of DMN-demethylase was not 
measured in this study, morphological evidence suggested 
that phenobarbital and ethanol administered concomittant- 
ly with DMN were not inducers of DMN-demethylase.
Immunocytochemical analysis of DMN-induced neo­
plasms was attempted using several commercial products 
and the avidin-biotin immunoperoxidase method. Selected 
tumors were examined for cytokeratin, vimentin, desmin, 
and Factor V U I - r e l a t e d - a n t i g e n  immunoreactivity.
Malignant hepatic tumors of endothelial origin showed 
strong immunoreactivity for vimentin and Factor VIII-RA, 
corroborating their endothelial origin. Renal mesenchymal 
tumors similarly exhibited a staining pattern which 
suggested a primarily vasoformative tendency, although 
this varied among tumors. Positive cytokeratin 
immunoreactivity varied with the primary antibody product 
used, but was noted in focal cell groups in pulmonary 
carcinomas usually associated with squamous metaplasia, in 
the benign tumors derived from biliary ductular
epithelium, and in sequestered and compressed renal 
tubules present in renal mesenchymal tumors and renal 
adenocarcinomas, respectively. Antibodies against 
cytokeratins were generally unsuccessful in labelling 
neoplasms derived from hepatocytes and proximal con­
voluted tubular epithelial cells.
xi v
INTRODUCTION
As continued chemicalization of our environment 
occurs, humans and their domestic animals are increasingly 
exposed to an everwidening variety of potentially 
carcinogenic chemical compounds. It is of utmost 
importance to understand the interrelationships between 
these environmental xenobiotics and their roles in cancer 
induction. This study was designed to investigate the 
effects of three compounds as well as partial liver 
removal, all of which affect the hepatic metabolism of a 
known carcinogen on tumor induction time, incidence, and 
target tissue.
Dimethylnitrosamine (DMN) was chosen because it could 
be administered in the form of relatively innocuous 
precursors, and it is a potent nitrosamine carcinogen 
which induces a relatively narrow spectrum of tumors. 
Metabolic manipulations included the administration of 
phenobarbital, which is an inducer of the cytochrome P- 
450 system, aminoacetonitri1 e , which is an inhibitor of 
the cytochrome P-450 system, partial hepatectomy, which 
provides a population of proliferating hepatocytes, and 
ethanol, which was present in the phenobarbital treatment 
and is also a cytochrome P-450 inducer.
The carcinogen was administered as aminopyrine and
xv
sodium nitrite in drinking water, allowing intragastric 
nitrosation and formation of D M N .
The specific objectives of this experiment were to:
1) Produce tumors in m a l e  F344 rats using the DMN 
precursors aminopyrine and nitrite.
2) To characterize the carcinogen-induced neoplasms by 
macroscopic, light microscopic, and ultrastructural 
examination as well as by immunocytochemical methods.
3) Examine the effects of various manipulations of the 
mixed-function-oxidase system on tumor numbers, types, and 
site of origin,
4) To utilize microsomal analysis of hepatic O-demethylase 
activity as a indicator of microsomal induction or 
repression and to compare this with morphological 
evidence of microsomal induction or repression.
5) To examine whether the avidin-biotin immunoperoxidase 





Since 1937 dimethylnitrosamine (DMN), a compound be­
longing to the carcinogenic nitrosamine family, has been 
known to have toxic effects in both animals and man (1,2). 
The first reports of acute toxicity studies in rats, 
mice, rabbits, guinea pigs, and dogs revealed that DMN 
produced severe hemorrhagic centrilobular necrosis in the 
liver, while sparing other organs (2). These early reports 
also suggested that DMN was probably metabolized in the 
liver, although the nature of the metabolic process was 
not discerned (2).
In the 1950's, the Norwegian herring industry began 
preserving herring with sodium nitrite. Feeding experi­
ments in various animal species using nitrite-preserved 
fishmeal revealed no initial toxicity, primarily because 
the experiments consisted of short trials composed of 
clinical observations only (3). However, it was later ob­
served that cattle and sheep fed herring meal as a pro­
tein supplement developed liver disease and succumbed (3), 
Liver disease was linked to nitrosamine (DMN) formation 
within the preserved meal (3).
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In cattle, the major hepatotoxic effect of DMN was 
an endophlebitis with prominent fibrosis of the hepatic 
vein and its branches as well as acute necrosis of hepato­
cytes with subsequent fibrosis of the liver (3). This 
endophlebitis, which was associated with an acute 
endothelial necrosis of the hepatic vein, resulted in 
edema of the blood vessel wall and proliferation of 
fibroblasts and smooth muscle cells (3). Hepatic pathology 
in cattle was only noted above a DMN threshold intake 
level of greater than 0.2mg/kg/day.
In pigs, a species much less sensitive to DMN than 
most others, the microscopic pathology of DMN is some­
what different as compared to ruminants (4). It was the 
sinusoidal walls in the porcine species that were af­
fected and thereby became permeable to plasma. The spaces 
of Disse became distended and perisinusoidal fibroblasts 
proliferated and produced collagen which ensheathed the 
collapsed sinusoids. Perisinusoidal fibrosis then pro­
gressed onto pseudolobule formation and diffuse cirrhosis 
(4). Acute hepatocytic necrosis was not a feature of DMN 
toxicity in swine (4).
In addition to hepatic lesions in swine, DMN also 
caused diffuse vascular changes, including proliferation 
of fibrocytes and smooth muscle cells in arterial walls 
that was severe enough to result in occlusion of affected 
vessels (4). Similar vascular changes were seen in ducks
administered DMN(4).
Except for the early reported cases of industrial 
exposure to DMN, humans are most likely exposed to con­
tinuous low levels of DMN in the diet. DMN is the most 
frequently found volatile nitrosamine in cheeses, beer, 
and nitrate-nitrite-preserved meats. In beer, contact of 
the malt with hot air containing nitrogen oxides is pro­
bably the primary route of contamination (5).
As mentioned previously, fish products preserved with 
nitrite have been found to be important sources of DMN (3). 
However, non-nitrite preservatives such as sodium benzoate 
and formaldehyde will also result in DMN formation in 
fishmeal. Even meal made from unpreserved, fresh fish has 
detectable levels of DMN (4).
Sources of DMN include those materials which contain 
nitrate, nitrite, and many amides and amites. Crops grown 
in nitrite-enriched soil are obvious sources (6,7).
Nitrate and nitrite occur in almost all water sources and 
these ions are readily taken up by growing plants (5). In 
addition, humans produce nitrites within their saliva (8).
A large proportion of drugs are tertiary amines and 
these react with ingested nitrites in the acidic environ­
ment of the mammalian stomach to produce DMN which is then 
primarily absorbed into the portal circulation in the duo­
denum (6). Two specific tertiary amines which react with 
nitrite to produce relatively high yields of DMN are the
analgesic, aminopyrine, and the antibiotic, oxytetracy- 
cline (6,7).
During early chronic DMN toxicity studies in rats, 
malignant hepatic tumors were induced, implicating DMN as 
a potent hepatocarcinogen (9). Subsequently, it was noted 
that the liver is not the exclusive target organ for DMN, 
as renal and pulmonary neoplasms had also been observed.
Chemical carcinogens have basically four different 
types of target cells in the liver (10). These include the 
hepatocytes, bile ductular epithelia, sinusoidal lining 
cells (including both endothelial cells and Kupffer cells) 
and perisinusoidal cells (Ito cells) (10). Sequential mor­
phological (andsometimes biochemical) cellular changes 
have been observed during the development of most of the 
tumor types derived from these different cell populations 
( 1 0 ) .
The first morphological stage in hepatocarcinogenesis 
involving the hepatocytes in the rat is the appearance of 
phenotypica 1 1 y altered foci of hepatocytes 
(10,11,12,13,14).
The earliest of these foci in a proposed progression 
is the clear focus, consisting of hepatocytes which store 
excess glycogen, and the acidophilic focus, which has in­
creased amounts of smooth endoplasmic reticulum (10). 
During the transformation of these clear/acidophi1 ic foci 
into basophilic foci a great variety of intermediate cell
types including fat-storing cells may be observed(14).
Basophilic foci consist of a homogenous population 
of small, basophilic cells, poor in glycogen but rich in 
free or membrane-bound ribosomes (10,14). Tigroid cell 
foci are a distinct population of cells whose prestages 
are unknown but resemble basophilic foci. Tigroid cells 
contain large and abundant basophilic bodies on a clear or 
acidophilic background (14).
The clear and acidophilic cells usually persist after 
withdrawal of the carcinogen and may progress through in­
termediate mixed and basophilic cell foci to neoplastic 
nodules (adenomas) and eventually to hepatocellular carci- 
mas (10), Preneoplastic foci similar to those seen in the 
rat have also been observed in other species, including 
primates (10).
Cytochemical changes arising in these phenotypically- 
altered foci in the liver include decreased activities of 
glucose-6-phosphatase, adenosine triphosphatase, acid and 
alkaline nucleases, glycogen phosphorylase, and adenylate 
cyclase. Alternatively, increased activities in the fol­
lowing enzymes are observed: gamma-glutamyltranspeptidase, 
glucose-6-phosphate dehydrogenase, epoxide hydrolase, uri- 
dine-diphosphate-glucoronyl-transpeptidase, various iso­
enzymes of cytochrome P-450, and glutathione transferases. 
In addition, a resistance to experimental hemosiderosis, 
an enhanced glutathione content and a loss of lipid per­
oxidation may be seen (10).
The cytochemical pattern of altered foci is rather 
heterogenous and is influenced by the dose and duration 
of the carcinogen treatment, the localization of lesions 
within the hepatic lobule and the age, sex, and strain of 
animal used (10).
In general, all hepatocarcinogens, including DMN, 
produce focal lesions prior to the development of hepatic' 
tumors. However, it has been found that rhe morphologic 
stages following exposure to hepatocarcinogens may also 
appear following conditions such as anaphylactic shock, 
orthostatic collapse, and protein deficiency (10). In 
principle, cellular alterations induced by these latter 
conditions are reversible. Many, or perhaps most, of the 
foci induced by a particular carcinogen may also be 
reversible after withdrawl of the carcinogen (15). 
However, there are persistent foci consisting of 
phenotypically-stable, altered hepatocytes which do 
progress to hepatocellular carcinoma (15,16).
The pattern of excess glycogen storage followed by 
loss of glycogen within altered hepatocytic foci suggests 
a genetically-induced alteration of cellular carbohydrate 
metabolism by the particular carcinogen. An initial dis­
ruption of carbohydrate metabolism results in excess ac­
cumulation of glycogen followed by a shift to alternate 
pathways of carbohydrate metabolim such as glycolysis or
the pentose-phosphate shunt (14,17). It is interesting to 
note that human patients suffering from inborn hepatic 
glycogenosis have a high incidence of hepatic tumors in 
those individuals who survive into adolescence (10,18),
Sequential morphological alterations are observed 
in carcinogen-induced tumors derived from biliary ductu- 
lar epithelial cells. The first step involves a nonspeci­
fic toxic effect of the carcinogen resulting in hepato­
cellular necrosis and reactive proliferation of ductular 
(oval cells) and mesenchymal cells (19). The oval cell 
proliferation leads to mucous cholangiofibrosis during 
which oval cells are converted to goble'rcells which 
store and secrete mucous substances containing acid and 
neutral mucopolysaccharides (10). This process is termed 
intestinal metaplasia or cholangiolar mucopolysaccharoid- 
osis (10).
After long lag periods expansive biliary tumors may 
develop from mucous cholangiofibrosis. There are two pos­
sible tumor types which can be seen and which may be de­
pendent on carcinogenic dose (20). Benign cholangiomas may 
develop which no longer synthesize excessive amounts of 
mucous substances and which are divided into two subtypes 
called simple and cystic cholangioma (20). Alternatively, 
cholangiofibromas may be produced which consist of glands 
producing large amounts of mucous substances within a 
thick stroma of collagenous fibers, Cholangiofibromas are
potentially malignant as they have been shown to trans­
form into cholangiocarcinomas (10). This malignant trans­
formation is accompanied by a progressive loss of mucous 
substances that were excessively produced by the chol­
angiof ibromas (19).
There is an obvious similarity between excess pro­
duction and storage of mucus in the carcinogen-induced 
neoplastic transformation of biliary epithelial cells 
with loss of mucus production with malignant transfor­
mation, and the excess storage and subsequent loss of 
glycogen by hepatocytes on their journey into malignancy.
Peliosis hepatis, benign hemangioendotheliomas, and 
malignant hemangioendothelial sarcomas are the possibly 
sequential, carcinogen-induced vascular endothelium-de­
rived lesions observed in the rat. Peliosis hepatis refers 
to cystic dilation of hepatic sinusoids or spaces of Disse 
(21). Because these dilations are often closely associated 
with benign hemangioendotheliomas and malignant hemangio- 
sarcomas, a controversial speculation of peliosis hepatis 
as an early stage in a possible neoplastic sequence in­
volving hepatic endothelial cells has been formulated (10, 
21). However, although a transition from benign to malig­
nant endothelial cells occurs in some experimental car­
cinogenesis studies, most malignant hemangiosarcomas ap­
pear to arise d_e novo (10).
As far as cytochemical disturbances which result in
excess storage and then removal of a particular product 
following malignant transformation, no such mechanism has 
been specifically described for vascular tumors. Some 
malignant endothelial cells contain cytoplasmic accumula­
tions of intermediate filaments of the vimentin type which 
may be indicative of a carcinogen-induced aberration in 
the production and/or degradation of these filaments (10, 
2 2 ).
Kupffer cell sarcomas are another neoplasm arising 
from sinusoidal lining cells in the liver and were once 
considered synonymous with hemangioendothelia 1 sarcomas 
(23). However, u 1 trastructura1 examination and 
cytochemical markers have revealed that these tumors are 
derived from resident hepatocytic macrophages, not from 
endothelial cells (24,25,26). Little is known about these 
particular neoplasms except that they are inducible in 
certain rat strains by trypan blue dye (25,26), so 
preneoplastic changes, if any, have not been studied.
The final cell in the liver which is a potential tar­
get for chemical carcinogens is the perisinusoidal cell, 
also known as the Ito cell, lipocyte, or fat-storing cell. 
These cells are located in the space of Disse and may be 
involved in the metabolism of vitamin A and in the produc­
tion of collagen (27,28,29).
Spongiosis hepatis is a cyst-like multilocular for­
mation filled with a finely granular flocculent acido­
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philic material. These spongiotic structures often occur 
after treatment of rats with various carcinogens and re­
place large areas of the liver parenchyma, neoplastic 
hepatocytic nodules, and hepatocellular carcinomas (27, 
28,29) .
Ultrastructurally, the walls of the ’'sponge” are com­
posed of fibroblastic-like cells which sometimes contain 
fat vacuoles and which strongly resemble perisinusoidal 
cells (10,27).
It is not known whether spongiosis hepatis is a pre­
neoplastic or a neoplastic liver lesion. There has been 
apparent transitions of areas of spongiosis hepatis into 
a malignant mesenchymal tumor called a pericytoma (10). At 
any rate, the accumulation of acid mucopolysaccharides 
within the spongiotic formations seems to disappear during 
the apparent transformation of spongiosis hepatis to peri­
cytoma. Once again, this pattern mimics those changes seen 
with malignant transformation in the hepatocyte and bile 
ductular epithelial cell (10,28).
DMN is able to induce renal neoplasia in addition to 
its hepatocarcinogenic effects. Renal tumors are most of­
ten associated with high doses of DMN given for relatively 
short periods of time, in contrast to DMN-induced hepatic 
tumors which are more likely to arise following small, 
chronically administered doses (30,31,32,33). Renal tumors
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are also common with single doses of DMN following such
experimental manipulations as a protein free diet or 
partial hepatectomy (33,34,35).
DMN is capable of producing predominantly two tumor 
types within the kidney; one derived from proximal tubu­
lar epithelial cells and the other from mesenchymal inter­
stitial cells (30,31,36,37,38,39). There is a clear 
bimodal distribution of these tumor types related to the 
age at which DMN treatment is initiated in rats (34). The 
renal mesenchymal tumor (RMT) is a neoplasm of the 
neonatal and sexually immature rat while cortical 
epithelial tumors are most prevalent in mature rats over 
three months of age (34). There is also an age influence 
on the degree of anaplasia of these respective tumors in 
rats. As rats reach sexual maturity the mesenchymal tumors 
tend to be histologically more we 1 1 -differentiated than 
those of less mature rats and the same is o b s e r v e d  for 
cortical epithelial tumors in older rats (10).
Early attempts at classification of DMN-induced renal 
neoplasms presented problems with the mesenchymal tumors 
due to its wide variety of morphological manifestations. 
Riopelle and Jasmin (36) suggested that the subdivisions 
of small-cell (mature), large-cell (immature), or inter­
mediate (maturing) be applied to the mesenchymal tumors 
depending on the predominant cell type observed histolo­
gically.
However, upon sequential histological and ultrastruc-
tural examination of DMN-induced mesenchymal tumors it was 
found that this classification scheme as well as the m u l ­
titude of terms arising in the literature to describe this 
particular tumor were overly complex, as they suggest an 
origin from different mesenchymal cellular elements and 
tended to obscure the true histogenesis of these tumors
(40.41.42.43), In fact, it appears that all of these tumor 
types arise from the same mesenchymal cell.
As for the hepatic tumors induced by chemical carci­
nogens, the renal mesenchymal neoplasms appear to undergo 
a sequence of morphological developments prior to the 
emergence of unequivocal malignancy (40,42,43,44). The 
first step is necrosis of cortical fibrocytes and endo­
thelial cells adjacent to the P2 segment of the proximal 
convuluted tubule where DMN is metabolized (40,42,43,44). 
An interstitial mononuclear inflammatory response occurs 
as an almost immediate response to DMN-induced toxic 
changes affecting the resident cortical fibrocyte and 
endothelial cells. Most of the cytotoxic response in 
proximal convuluted epithelial cells follows necrosis of 
the fibrocytes and endothelial cells and is believed to 
be the result of anoxia induced by necrosis of adjacent 
blood vessels (44). The number of macrophages within in­
flammatory foci decrease with time, with a corresponding 
increase in the number of plasma cells and lymphocytes
(40.42.43.44). Later, abnormal fibroblast-like cells are
noted within hypercellular foci; these persist while the 
number of mononuclear cells gradually decreases
(40.42.43.44) .
As these fibroblast-like cells proliferate to 
eventually form the mesenchymal interstitial neoplasms 
they can differentiate into a number of mesenchymal cell 
types indistinguishable from pericytes, endothelial cells, 
vascular smooth muscle cell, and rhabdomyoblasts
(40.42.43.44). This spectrum of differentiation seen in 
these tumors is within the capability of the resident 
cortical fibrocyte, a cell which remains sufficiently 
unspecialized in adult tissue as to have the potential to 
serve as a precursor for numerous cell types (44,45).
These cells make up the mesenchymal cell elements which 
accompany the ingrowing capillaries during renal 
embryogenesis and which subsequently differentiate into 
mesangial cells of the glomerulus and smooth muscle cells 
of the a r t e r i o l e s  (40,42,43,44,45).
Epithelial tubular elements often found within me­
senchymal tumors are believed to be pre-existing nephric 
elements which are the "victims" of sequestration and 
compression by the infiltrative malignant interstitial 
tissue, rather than representing the potential of the 
resident cortical fibrocyte to act as a precursor for both 
epithelial and mesenchymal elements (43,44,45,39).
In the development of DMN-induced renal adenocarci—
nomas, sequential cellular alterations, which can be com­
pared to those seen in hepatocytes undergoing carcinogen- 
induced, premalignant changes, have been described 
(37,41). These include the appearance of tubules lined by 
atypical epithelial cells, through adenomas, to eventual 
carcinomas (37,41). However, the metabolic alterations 
resulting in the accumulation of substances (i.e. 
glycogen) have yet to be as well-characterized as those in 
liver neoplasms, although similar granular acidophilic and 
clear cells are seen in both rodent and human renal 
cortical epithelial neoplasms (37,46). There is a variant 
of renal adenocarcinoma known as clear cell adenocarcinoma 
in which the neoplastic cells accumulate excess glycogen 
and lipid, which may be comparable to the hepatic 
neoplastic process, but these tumors are rare in rats 
r e c e i v i n g  DMN (30,31,47).
The only other relatively common site of origin of 
tumors seen with DMN exposure in rats is the lung (30). 
Pulmonary neoplasms have not been a consistent finding 
in DMN carcinogenesis studies and unlike DMN-induced hepa­
tic and renal tumors, which are derived from epithelial 
and mesenchymal cellular elements, pulmonary tumors 
described so far have been only epithelial in nature 
(30,48-52).
There appears to be a progression of carcinogen- 
induced alterations from foci of hyperplasia, through a-
denomas, to the final stage of malignant adenocarcinoma 
(48,49,50). Thus, a similar storyline is weaved within 
the confines of the lung, as was seen in the liver and 
kidney affected by DMN.
The cell of origin in F344 rat, nitrosamine-induced 
pulmonary neoplasms is proposed to be the alveolar type II 
epithelial cell, based on ultrastructural studies on both 
adenomas and adenocarcinomas (51,52). This is in sharp 
contrast to nitrosamine-induced pulmonary tumors seen in 
Syrian golden and European hamsters, which have also been 
studied at the ultrastructural level, and are derived from 
a number of different cell types, including c i l i a t e d  
cells, clara cells and Kulchitsky (APUD) cells (51,52).
The fact that alveolar cell hyperplasia, which is 
thought to be an early stage in the carcinogenic sequence, 
predominantly consists of type II pneumocytes which h a v e  
a high mitotic potential is supportive of this cell as the 
cell of origin for alveolar/bronchiolar neoplasms in the 
rat (48). It must be remembered, however, that ciliated 
cells, clara cells and APUD cells can all participate to 
some degree as the cellular constituents of focal hyper­
plasia (48). The book on the possible cell types seen 
within pulmonary neoplasms is not at all closed.
Like most chemical carcinogens, DMN is a procarcino­
gen which must be converted to a metabolite, the ultimate 
carcinogen, before it can exert its toxic/carcinogenic
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effects. As noted previously, early evidence suggested 
that DMN is rapidly metabolized primarily within the liver 
since cellular damage was almost exclusively localized 
here (53). This provided a clue that a metabolite of DMN, 
rather than the compound itself, was responsible for the 
toxicity observed (53).
DMN is oxidatively demethylated in the target tissue 
to monomethylnitrosamine which undergoes nonenzymatic de­
composition to diazomethane or to an alkylating agent, the 
carbonium ion (54). This process occurs mainly in the liver 
and, to a lesser extent, in the lungs, kidneys, and other 
organs. The carbonium ion alkylates cellular macromole­
cules such as DNA, RNA, and protein (55).
Organotropism of DMN is highly dependent on the dose 
administered. Generally, with low chronic doses DMN is 
a liver carcinogen, whereas at high doses for short dura­
tions, DMN is primarily a renal carcinogen (57,58). There 
is extensive first-pass metabolism of DMN in the liver 
but this system is saturable at high doses of the com­
pound, allowing systemic(exposure to DMN (57).
The enzyme system responsible for DMN metabolism 
is located in the smooth endoplasmic reticulum of hepa­
tocytes and is a P-450— dependent monooxygenase activity 
which requires NADPH and oxygen (54). Reduction of hepatic 
microsomal enzymes concerned with the metabolism of DMN 
has the effect of revealing additional target organs,
specifically the kidneys or lungs. This reduction has 
been achieved in many experimental manipulations such 
as partial hepatectomy (58,59,60), carbon tetrachloride 
administration (61), or through'dietary manipulation 
with a low protein, high carbohydrate diet (34,61,62).
Single doses of DMN following partial hepatectomy 
and carbon tetrachloride administration also have the 
effect of increasing the number of hepatic tumors eventu­
ally appearing in rats subsequent to these respective ma­
nipulations. Partial hepatectomy and carbon tetrachloride 
administration reduce DMN-demethylase activity by essen­
tially removing a large functional part of the organ but 
also stimulate a marked increase in DNA synthesis as­
sociated with an increased mitotic rate. There is a cor­
relation between the amount of DNA synthesis and the 
number of hepatic tumors arising (58,61), This is due to 
the fact that the metabolites of DMN, most likely the car­
bonium ion (54,63), act as alkylators of cellular DNA, 
providing the initiating event in DMN carcinogenesis.
The eventual appearance of preneoplastic and neoplastic 
morphological changes requires the persistence or fixa­
tion of the genetic damage induced by the carbonium ion 
through an increased mitotic rate provided by the stimulus 
of partial hepatectomy or cellular loss with carbon tetra­
chloride (58,61).
Of the products of alkylation of DNA by the carbonium
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ion, O^-methylguanine appears to be one of the most impor­
tant. Production of O^-methy1 guanine is related to the 
carcinogenic effects of alkylating agents, as it is noted 
that organs which tumors most frequently arise are gener­
ally those in which O^-methylguanine in DNA persists or 
accumulates (55,64). This has also been attributed to the 
fact that the target organs may have a lower efficiency of 
an enzyme system which can effectively remove damaged por­
tions of the DNA molecule (55). Chronic administration of
£
DMN increases the capacity of the liver to excise 0 - 
methylguanine from DNA. However, chronic DMN administra­
tion also increases the rate of DNA synthesis approximate­
ly five times in the liver and doubles it in the kidney 
and lung (55). An increase in DNA synthesis may then be 
more important than the persistence of DNA damage in re­
gards to the initiation of tumors (55).
It has been proposed that DMN-demethylase exists in 
at least two isoenzymic forms called DMN-demethylase I 
and II. DMN-demethylase I is active at low substrate con­
centrations and is repressed by many of the classical in­
ducers of the mixed-function-oxidase (MFO) system such as 
phenobarbital, pregnenolone-16 alpha-carbonitrile, 3-me- 
thylcholanthrene, and beta-napthoflavone. In contrast, 
DMN-demethylase II is active at higher substrate concen­
trations and is induced by the classical MFO inducers (54, 
65,66,67,68,69, 70,71,72) .
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This two isoenzyme system is probably an oversimpli­
fication, as at least three Km values have been reported 
for DMN in untreated rats, and additional Km values have 
been reported for phenobarbital-treated rats (73). These 
different isoenzymes probably have differing affinities 
for the nitrosamine substrate. The major forms of P-450 
induced in the rat liver by phenobarbital, polycyclic hy­
drocarbons, and polychlorinated biphenyls probably have 
low affinities for DMN. So at low substrate concentrations 
there is a repression of demethylase activity because 
there is competition between the induced low-affinity iso­
enzymes and the existing higher-affinity isoenzymes (7). 
When the DMN concentration is increased, there is a corre­
sponding increase in demethylase activity due to the nu­
merous isoenzyme forms induced by the MFO inducers (73).
Other ways of nitrosamine bioactivation have been 
proposed. One is a cytochrome P-450 dependent reductive 
denitrosation (74), and the other is a cytochrome P-450 
independent mechanism utilizing a microsomal amine oxidase 
(75).
The concluding segment of this review will provide 
a general background on intermediate filaments, as immuno- 
cytochemistry utilizing these cellular components as 
markers was a major part of this dissertation. Since this 
is a comparatively new and evolving branch of diagnostic 
pathology, the more recent findings in the literature which
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pertain to specific results obtained in this study will be 
presented as part of the discussion in the chapter dealing 
with immunocytochemistry.
Intermediate filaments (IFs) have been the most recent 
cellular constituent that has been heralded as a means of 
cellular identification and may serve as molecular mark­
ers of considerable specificity of cell differentiation 
which could be helpful in identification and classifica­
tion of tumors of equivocal and nonspecific histology and 
obscure histogenesis (76). One of the most important cri­
teria for the choice of cancer therapy is the determina­
tion of the origin of the neoplastic growth (77).
IFs are structural cellular proteins which vary be­
tween 7 and llnm in diameter and, along with microtubules 
and microfilaments, make up the cytoskeleton of almost 
all vertebrate cells (78,79,80). The diameter of IFs is 
intermediate between microfilaments (6nm) and microtubules 
(25nm) which usually allows for identification in electron 
micrographs. 'Additional characteristic ultrastructural fea­
tures are that IFs are rarely straight and lateral associa­
tion of at least certain IF types is common (79). They are 
also present in coil- or whirl-like arrangements in the 
perinuclear space (79).
IFs constitute a chemically heterogenous class of 
subunit proteins which differ in their antigenicity. This 
is in contrast to the situation found in the two other
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cytoplasmic filament systems, microtubules and microfila­
ments, each of which only consists of one basic type of 
protein unit (76,77).
IFs present in diverse cell types do share some char­
acteristic features such as unbranched tubular architec­
ture, a high degree of alpha-helical conformation, and a 
considerable resistance to denaturing solvents (76). IF 
proteins vary in size from class to class as well as from 
species to species (80). Their chemical and immunological 
diversity as well as their structural similarity has been 
proposed to be due to a common structure of alpha-helical 
domains, which are separated by five varying globular do­
mains (80) .
Within the adult animal, five distinct subgroups of 
IFs occur (76,79). Cytokeratins (AO,000 to 68,000 daltons) 
are present in various cells of epithelial differentiation 
and contain similar, although not identical, polypeptides 
related to epidermal prekeratin (76,79). In contrast to the 
other IF types of vimentin, desmin, and glial f i l a m e n t s  
which consist usually of only subunit protein type, the 
cytokeratin filaments are a complex family of many differ­
ent polypeptides (81). Cytokeratins are expressed in dif­
ferent epithelia, in different combinations of polypep­
tides ranging from 5 to 8 in their isoelectric pH values 
and in their apparent molecular weights (81).
Up to 19 different human cytokeratin polypeptides
.have been identified and epithelial cells contain vari­
able proportions of a number of these (81). Some of these 
polypeptides may be specific for a distinct epithelial 
type, while others may be specific for a particular stage 
of differentiation (82).
Malignancies usually express the same type of IFs, 
even in metastases, as found in their tissue of origin 
(78,79,83). The different types of IFs morphologically, 
immunologically, and biochemically remain practically 
constant in the corresponding normal and neoplastic cells 
(78). However, while there are certain types of carcinomas 
which display cytokeratin patterns closely related to the 
cytokeratin distribution in their tissues of origin, other 
carcinomas express additional cytokeratins or delete poly­
peptides from the normal keratin complement (77). Also, no 
significant differences exist between the cytokeratin con­
tents of primary and metastatic tumors provided that the 
metastatic cells form a solid, three-dimensional tissue 
structure (77). If metastatic carcinoma cells proliferate 
in serous cavity effusions, they acquire the potential to 
express vimentin (77).
Vimentin (57,000 daltons) is the IF of mesenchymal 
tissue and various cultured cells (76,79). Most cells of 
different embryological origin start to produce vimentin 
when grown in vitro (77). Vimentin is also expressed se­
quentially during the differentiation of various cell
lineages and is sometimes sustained in the fully differ­
entiated tissue (77). Vimentin is the predominant IF in 
early myoblastic cells and is later supplanted by desmin 
as maturation proceeds (76). A similar situation exists 
during neuronal and glial cell development (76). Tissues 
which have been classified as epithelial but which con­
tain vimentin filaments are ocular lens cells, lining 
cells covering the iris and ciliary body, and retinal 
pigment epithelial cells (77).
Vimentin has been localized in astrocytes, glioma 
cells, Schwann cells, Muller glia of the retina, cells of 
the pia, meninges and ependymal cells, and glia which is 
either immature, periventricular, radial or present in 
nonmyelinated white matter. Vimentin coexists with neuro­
filament protein in the outer plexiform layer of the adult 
retina and with glial fibrillary acidic protein in the 
astrocytes of myelinated fibers (77).
Additionally, vimentin has also been found in endo­
thelial cells, chondrocytes, various circulating blood 
cells, epidermal melanocytes, Langhans cells, sertoli 
cells, Kupffer cells, ovarian granulosa cells, and fibro­
blasts (77) .
Desmin (54,000 daltons) filaments are constituents of 
various types of muscle cells (76,79). In skeletal muscle, 
desmin is localized in the Z lines and regions of cell­
cell juncture (77). In cardiac muscle, desmin is associ-
a ted with the intercalating discs and Purkinje fibers 
(77). Vascular smooth muscle cells contain both desmin and 
vimentin filaments, with vimentin predominating (77,83).
Glial fibrillary acidic protein (GFAP) (55,000 dal­
tons) is selectively localized in astroglia and their pro­
cesses in the central nervous system, although it is oc­
casionally coexpressed with desmin (77,79), GFAP is exces­
sively produced in response to injury of the astroglia. 
GFAP has been localized in certain cells of the enteric 
nervous system of the intestine which suggests these cells 
are related to astrocytes of the CNS (77). Certain cells 
also coexpress vimentin and GFAP, such as astrocytes in 
myelinated fibers (77).
Finally, neurofilaments (three polypeptides of 
68,000,160,000, and 200,000 daltons) are almost 
exclusively localized in nervous tissue (77,79), They are 
generally found within myelinated nerve fibers of the 
central and peripheral nervous system. In the peripheral 
nervous system they are localized in neuronal cell bodies 
of spinal sensory nerves as well as in the myelinated 
fibers (77). In the CNS , neurofilament proteins are 
predominantly found in the myelinated axons (77).
The cellular distribution of each subunit of the 
neurofilament triplet is not equal (77,79). The 200,000 
dalton protein is distributed differently to the 68,000 
and 160,000 dalton proteins in mature and developing
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brain (77).
The only mammalian coexpression of another IF seen 
with neurofilaments thus far is the coexpression of vi­
mentin and neurofilaments in the horizontal cells in the 
outer plexiform layer of the retina (77). In immature 
chickens, the 68,000 dalton neurofilament triplet has 
been detected in the erythrocyte, coexisting with vimen­
tin (77).
CHAPTER II
DMN-induced Hepatic, Renal, and Pulmonary Neoplasms in 
Male Fischer 344 Rats with Various Manipulations of the 
Mixed-Function-Oxidase System: Gross, Light Microscopic, 
and Ultrastructural Findings
ABSTRACT
Male Fischer 344 rats administered aminopyrine and 
nitrite as precursors of DMN developed various numbers 
of hepatic, renal, and pulmonary tumors depending on 
the nature of the manipulation of the mixed-function-oxi- 
dase system performed. Partial hepatectomy resulted not 
only in a number of hepatic tumors, but in renal and pul­
monary tumors as well. Aminoacetonitrile did not have a 
pronounced sparing effect on the liver but appeared to 
shift a proportion of DMN metabolism to the kidneys and 
lungs, where tumors also arose. Ethanol and phenobarbital 
seemed to h a v e  a ge n e r a l  s p a r i n g  effect on the liver, as 
no benign or m a l i g n a n t  h e p a t i c  n e o p l a s m s  arose within 
these groups during the 36 weeks a n i m a l s  were g i v e n  the 
carcinogen. This sparing effect did not extend to other 
organ systems.
DMN-induced neoplasms noted in the liver, kidneys, 
and lungs were comparable to those described previously 
in the literature for gross, histologic, and ultrastruc-
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tural examination.
An overwhelming majority of rats on the carcino­
genic regime developed hyperplastic/preneoplastic 
pulmonary lesions, perhaps indicative of a particular 
target organ susceptibility in this rat strain.
INTRODUCTION
D i m e t h y l n i t r o s a m i n e  (DMN) is a potent 
hepatocarcinogen with the ability to induce various tumor 
types following its metabolism to an alkylating agent by 
the mixed-function-oxidase system in the liver (9,53,54). 
DMN-induced hepatic tumors are primarily derived from the 
hepatocyte or the sinusoidal endothelial cell (9,84). 
Frequency of these tumor types varies among different 
reports, but a very high incidence of hemangioendothe1ia1 
sarcomas has been associated with providing DMN in the 
form of aminopyrine and nitrite in the drinking water of 
Sprague-Daw1ey rats (85). For the hepatocyte-derived 
neoplasms there is a step-like sequence of morphological 
and biochemical changes associated with increasing 
malignant potential (10-18). Such a detailed sequence for 
endothelial-derived neoplasms has not yet been 
definitively ascertained (10,21,22).
In the kidney, the metabolites of DMN act either on 
the epithelial cells of the proximal convuluted tubule to 
produce adenomas and carcinomas, or the resident corti­
cal fibrocyte, a multipotential stem cell, to produce the
renal mesenchymal tumor (37,38,39). Sequential changes 
leading to eventual malignancy are proposed for both the 
cells of origin of these tumor types (36-43,48-52).
Pulmonary neoplasms reported with DMN have not been 
common (30). So far, they have only consisted of tumors 
exclusively epithelial in nature. In recent reports in 
which pulmonary tumors induced by riitrosamines other than 
DMN have been examined ultrastructurally, the cell of 
origin has been the alveolar type II pneumocyte (51,52). 
Again, a proposed sequence incorporating a range of 
changes from hyperplasia to malignant carcinoma has 
been suggested for this cell type (51,52).
MATERIALS AND METHODS
140 m a l e  Fischer 344 rats were obtained from a c o m ­
mercial s u p p l i e r  at 4 weeks of age and were permitted to 
acclimate to their surroundings for over two weeks before 
being randomly selected into experimental and five control 
groups.
All rats within the various experimental groups (to­
tal of 100 animals) received 1 mg of aminopyrine (Aldrich 
Chemical Company,In c .) and 1 mg of sodium nitrite (Sigma 
Chemical Company,Inc.) per ml of tap water, supplied at 20 
ml/rat/day. 24 rats received only aminopyrine and nitrite 
in their drinking water without further experimental 
manipulation [CARC], 8 rats received regular tap water at 
20 ml/rat/day [C0NT],
The following experimental manipulations were per­
formed: partial hepatectomy, aminoacetonitrile injections, 
and administration of either phenobarbital (1.75% ethanol) 
or 1.75% ethanol alone in the drinking water.
Partial Hepatectomy:
This group included 24 carcinogen-treated rats [CARC- 
PH] and 8 control rats [CONT-PH], M ethoxyf1 urane at a 
concentration between 1 and 3% was used for both induction 
and maintenance of surgical anesthesia. A midventral 
abdominal incision, about 2 cm in length, was made just 
caudal to the xiphoid cartilage. The left lateral lobe of 
the liver was exteriorized and a ligature of 2-0 chromic 
gut was tied around its base. The pressure applied when 
tying this ligature was sufficient to prevent significant 
intra-abdominal hemorrhage, but at the same time not to 
promote extensive necrosis of the parenchymal stub which 
was returned to the abdominal cavity. One-third of the 
liver parenchymal mass was effectively removed by this 
technique. The abdominal wall incision was closed with 2-0 
chromic gut and the skin i n cision was c l o s e d  with 2-0 
Ethilon. Rats were placed in a separate recovery cage, 
allowed to fully awaken from anesthesia, and then returned 
to their regular cages. These rats were closely observed 
over the next few days with particular attention being 
given to the surgical incision site.
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Aminoacetonitrile (AAN):
There were 24 carcinogen-treated rats [CARC-AAN] and 
8 control rats [CONT-AAN] in this group. 20 mg of 
arainoacetonitrile (Sigma Chemical Company) in .2 ml sterile 
saline, pH adjusted to 7.4, was administered as a 
subcutaneous injection three times weekly on alternate 
weekday mornings.
Phenobarbital (1.75% ethanol):
There were 24 rats which received the carcinogens and 
phenobarbital/ethanol [CARC-PB] and 8 rats which received 
only phenobarbital/ethanol [CONT-PB]. Phenobarbital was 
provided at a concentration of 0.5 mg phenobarbita1 /ml tap 
water. The particular formulation of phenobarbital used 
was an elixer (Eli Lilly Drug Company) containing 14% 
ethanol, so the rats in these groups received 1.75% 
ethanol in addition to the above concentration of 
phenobarbital.
1.75% Et h a n o l :
4 rats were given the carcinogen plus ethanol [CARC- 
eth] and 8 rats were given ethanol without the 
carcinogen [CONT-eth]. Drinking water provided for these 
animals contained as a volume/volume relationship, 1.75% 
absolute ethyl alcohol (AAPER Alcohol and Chemical 
Company) in tap water. This group was included to serve as 
alcohol controls for evaluation of the phenobarbita1- 
ethanol group.
Animals received treated water five days per week and 
regular tap water on weekends. Treated water and regular 
water was provided at 20 ml/rat/day ad libitum. Treatment 
solutions were made fresh once weekly and stored at 4°C. 
Drinking water was changed twice weekly for all rats, and 
water consumption was measured and recorded in ml consumed 
per cage.
Rats were housed in groups of four in opaque or 
clear plastic cages with wire tops. Purina Rat Chow was 
provided ad libitum. Cagemates were weighed as a group 
once a week on Monday mornings and weights were recorded.
One-fourth of the rats in each respective treatment 
and control group was killed at four weeks, twelve 
weeks, twenty-four weeks, and thirty-six weeks.
Rats were killed by ether (Mallinckrodt,Inc.) over­
dose and were submitted to complete necropsy examination. 
Body weights and liver weights were recorded.
Pooled samples of fresh liver, approximately 2 grams 
per rat, were stored in glass v i a l s  at -60°C in a Forma 
Bio-Freezer (Forma Scientific, Marietta,Ohio) until p- 
nitroanisole assays for microsomal activities could be 
performed. With smaller experimental and control groups, a 
more substantial amount of liver parenchyma was saved per 
animal in order to obtain a total pooled weight of between 
8 and 12 grams.
Diced samples of liver and selected extrahepatic neo-
plasms were fixed in 4% formaldehyde 1% glutaraldehyde 
(4F1G) for future transmission electron microscopy and 
stored at 4°C until they could be processed.
Sections of liver and kidney from each rat were 
fixed in absolute ethyl alcohol or in 100% acetone 
for 24 hours at 4°C. Acetone sections were then embedded 
in paraffin. Alcohol-fixed tissue sections were further 
dehydrated in acetone before being embedded in paraffin.
Similarly, sections of liver and kidney were fixed in 
10% neutral buffered formalin (NBF) for 24 hours, 
routinely processed and paraffin-embedded.
Representative tissue samples from all organs were 
fixed in 10% NBF for up to two to three weeks before be­
ing routinely processed and paraffin-embedded. Hematoxylin 
and eosin stained 6um sections of the following tissues 
were routinely examined by light microscopy from each 
animal: heart, lungs, liver, kidneys, spleen, tes­
ticles, adrenals, and stomach.
After fixation in 4FIG, tissue samples for transmis­
sion electron microscopy were washed in 0.1M sodium caco- 
dylate buffer containing 5% sucrose, and were postfixed in 
osmium tetroxide in 0.1M sodium cacodylate. Samples were 
then dehydrated through a graded series of alcohols, rang­
ing in concentration from 30 to 100% ethanol. Samples were 
then infiltrated with mixtures of epoxy resin (epon-aral- 
dite) and propylene oxide in concentration ratios (epon-
araldite:propylene oxide) of 25%:75%, 50%:50%, and 75%: 
25%. Embedding was performed with 100% epon-ara1 dite and 
specimens were allowed to polymerize for 24-48 hours at 
60°C. Thin sec t i o n s  were cut on a S o r v a l l  MT 5000 
ultramicrotome (Ivan Sorvall,Inc. Norwalk,CT) and were 
stained with uranyl acetate and lead citrate. Sections 
were then examined on a Zeiss EM 10 transmission electron 
microscope (Carl Zeiss,Inc, New York,NY).
Statistical analysis was carried out by a completely 
randomized design with factorial treatment arrangement.
Two covariables (water consumption and liver/body weight) 
were added to the model. Superimposed on this was a 
multivariant analysis of variance to justify the treatment 
s i g n i f i c a n c e  of the five tumor types induced. Duncan's 





Very few hepatic abnormalities were noted at this 
time. Surprisingly, the most severe hepatic lesions were 
limited to the control group receiving subcutaneous 
injections of aminoacetonitri1 e [C0NT-AAN], Both rats from 
this group had focal, 4x5mm, light tan, irregular areas in 
the right lateral liver lobes. Control and treated rats
which had undergone partial hepatectomy surgery had a 
yellow-tan friable tissue adhered to the excision site at 
the base of the left lateral lobe.
Liver-Microscopic Examination
Many rats in both control and carcinogen-treated 
groups had slight portal infiltrates of lymphocytes and 
plasma cells. Carcinogen-treated partial hepatectomy,
AAN, and phenobarbital (1.75% ethanol) rats had very 
slight proliferation of biliary ductular cells. Two CARC- 
PH rats and one CARC-AAN rat exhibited mild to moderate 
hepatic cell dysplasia. Dysplastic hepatocytes were 
enlarged and contained markedly enlarged, hyperchromatic 
nuclei. Cytoplasm was eosinophilic with slightly granular, 
basophilic borders. These hepatocytes lacked normal 
arrangement into hepatic cords and formed irregular 
s i n u s o i d a l  spaces (Fig. 1).
CONT-AAN rats had well-demarcated regions of par­
enchymal necrosis bordered by fibroblastic cells and mild 
to moderate bile duct hyperplasia. Some bile duct epithe­
lial cells had undergone intestinal metaplasia with slight 
intraluminal accumulation of mucus, and were surrounded 
by focal areas of moderate fibrosis. Slight proliferation 
of biliary ductular cells were noted in portal areas sur­
rounding necrotic regions.
CARC-PH and CONT-PH rats had areas of moderate fibro­
sis at the surgical site. Focal areas containing mineral-
Fig. 1: Hepatic cell dysplasia. HE. 20X
Fig. 2: TEM, hepatocytes, CARC, 4weeks. Minimal 
ultrastructural changes. 5800X Bar=lum
ized debris were surrounded by multinucleated giant cells 
and hemosiderin-laden macrophages. Occasional slight, 
well-demarcated areas of hepatocytic necrosis were noted 
adjacent to the surgical site.
Additional histologic lesions occured in the lungs 
and hearts of both control and carcinogen-treated animals. 
In the lungs there was slight to moderate hyperplasia of 
bronchiolar associated lymphoid tissue (BALT) and 
scattered perivascular accumulations of lymphocytes, 
plasma cells, and macrophages. These monocytic 
infiltrations extended along alveolar septa and there was 
slight hyperplasia of alveolar lining cells. One CARC-PB 
rat had very marked hyperplasia of BALT and marked 
bronchiectasis with severe intraluminal accumulations of 
neutrophils.
Cardiac lesions were mild and consisted of slight 
monocytic interstitial infiltrations. Occasional loss 
of myofibers was noted accompanied by slight to moderate 
histiocytic infiltrates.
Liver-Ultrastructural Examination
CARC (Fig. 2) (-PH,-AAN,-PB,-eth) rats: Proliferation of
smooth endoplasmic reticulum (SER) often with associated 
with glycogen particles was seen in all groups but 
particularly prominent in PH, AAN, PB, and eth. groups 
where there was displacement of other cellular organelles
into di s c r e t e  groups as a r e s u l t  of the marked 
proliferation (Fig. 3). Cytoplasmic vacuoles containing 
slight to moderate amounts of a flocculant material were 
noted in hepatocytes of treated rats receiving PB. In the 
treated rat receiving ethanol, mitochondrial shapes were 
slightly elongated and distorted and there was slight 
disruption of lamella of rough endoplasmic reticulum 
(RER).
CO NT ( - P H , - A A N , - P B , - e t h ) r a t s :  No s i g n i f i c a n t  
u 1 1 r a s t r u c t u r a  1 a b n o r m a l i t i e s  were noted in controls. A 
few h e p a t o c y t e s  were o b s e r v e d  which con t a i n e d  a few fat 




L i v e r s  f r o m  c a r c i n o g e n - t r e a t e d  rats, w i t h  the 
e x c e p t i o n  of C A R C - P B  and C A R C - e t h  g r o u p s  c o n t a i n e d  
m u l t i f o c a l ,  discrete, sph e r i c a l ,  tan, l-2mm in diameter 
nodules visible on the capsular surface or on section. In 
these groups, some l i v e r s  had s l i g h t l y  rounded edges or 
enlarged, rounded lobes. Hep a t i c  co l o r  ranged from dark 
r e d-brown to tan. The most s e v e r e l y  af f e c t e d  rats were 
those in the C A R C - A A N  group. Four out of the six rats 
e x a m i n e d  at t h i s  ti m e  had g r o s s l y  v i s i b l e  h e p a t i c
neoplastic nodules (adenomas) (Table I). CARC and CARC-PH 
rats were comparitive1 y less affected. Rats in the various 
control groups had no gross hepatic abnormalities. Livers 
from CARC-PB and CARC-eth rats were strikingly normal in 
gross appearance.
Lung-Gross Examination:
One C A R C - P B  rat was k i l l e d  due to s e v e r e  dyspnea. The 
lungs had numerous 3-Amm nodules which contained a yellow 
c a s e o u s m a t e r i a  1 on s e c t i o n .T h e s e  c a s e o u s  n o d u l e s  
effectively replaced most of the normal lung parenchyma. 
Liver-Microscopic Examination:
A majority of carcinogen-treated rats had slight bile 
d u c t u l a r  and p e r i d u c t u l a r  e p i t h e l i a l  p r o l i f e r a t i o n .  
Carcinogen-treated rats, with the exception of those on PB 
or ethanol,had areas of m o d e r a t e  to marked h epatic ce l l  
dysplasia. Most of these also had several altered foci of 
hepatocytes including acidophilic/clear cell, mixed, and 
basophilic cell varieties. These foci were less than the 
size of a t y p i c a l  hepatic l o b u l e  in diameter, had 
irregular borders, but showed no evidence of invasion of 
surrounding parenchyma or of compression by expansion 
(Fig. 4).
Acidophilic/clear cell foci were mixtures of altered 
hepatocytes with abundant amounts of either a finely gran­
ular, eosinophilic or clear cytoplasm.
Mixed cell foci consisted of several populations of
TABLE Liver, tumor numbers listed as a function
of time (kill interval)
Adenoma/CA # 
1 2 3 4 T 1
HES 
2 3 4 T
CARC (24 rats) 0 1 4 6 11 * 0 0 0 1 1
CARC-PH (24 rats) 0 1 6 6 13 * 0 0 0 3 4 **
CARC-AAN (24 rats) 0 4 3 3 10 * 0 0 0 0 0
CARC-PB (24 rats) 0 0 0 0 0 0 0 0 0 0
CARC-eth (4 rats) 0 0 0 0 0 0 0 0 0 0
CONT (8 rats) 0 0 0 0 0 0 0 0 0 0
CONT-PH (8 rats) 0 0 0 0 0 0 0 0 0 0
CONT-AAN (8 rats) 0 0 0 0 0 0 0 0 0 0
CONT-PB (8 rats) 0 0 0 0 0 0 0 0 0 0
CONT-eth 0 0 0 0 0 0 0 0 0 0





# = significant difference in tumor no. means between
carcinogen and noncarcinogen groups (Duncan's)
@ = no significant difference in tumor no. means be­
tween carcinogen and noncarcinogen groups (Duncan's)
* = significantly higher incidence of tumors (Duncan's)
** = significantly higher incidence of tumors compared to
CARC-PB, CARC-eth, and CARC-AAN, but not CARC 
(Duncan * s)
Duncan's = Duncan’s Multiple Range Test
TABLE II Statistical Evaluation: hepatocytic 
neoplasms
Source DF Mean Square Pr>F
liver/body wt. 1 1.65108223 0.0001**
water 1 0.00068349 0.9350
treatment 4 1.00163601 0.0001**
carcinogen 1 2.36867544 0.0001**
time 1 2.46395035 0.0001**
t *t 1 1.58995121 0.0577
T*Carc 1 1.58995121 0.0001**
T*T*Carc 1 0.16455601 0.2075
Error 128 0.10251200
* significant (P<.01)
** highly significant (P<.01) 
T*T treatment/ time 
T*Carc time/carcinogen 
T*T*Carc treatment/time/carcin ogen
DF degrees of freedom
TABLE III 
Source
Statistical Evaluation: Endothelial 
neoplasms, liver
DF Mean Square Pr>F
liver/body wt 1 0.02936938 0.1937
water 1 0.72657360 0.0001**
treatment 4 0.02574859 0.2070
carcinogen 1 0.48929103 0.0001**
time 1 0.07802428 0.0351*
T*T 1 0.00614277 0.5512
T*Carc 1 0.17562109 0.0018**
T*T*Carc 1 0.07588161 0.0377*
Error 128 0.01720169





DF degrees of freedom
altered hepatocytes including cells with abundant eosino­
philic cytoplasm, cells with small nuclei and with moder­
ate amounts of a basophilic cytoplasm, as well as hepato­
cytes with bars or clumps of a basophilic material on a 
background of abundant eosinophilic cytoplasm. These lat­
ter cells corresponded to the typical tigroid cell.
Foci consisting exclusively of the smaller basophi­
lic cells were occasionally observed. These foci usually 
had increased mitotic figures.
The greatest variety of altered foci were observed 
within rats of the CARC-AAN group. These livers, as 
mentioned previously, also contained more numerous neo­
plastic nodules. Neoplastic nodules consited of solid 
aggregates of atypical hepatocytes. Characteristics of 
these nodules included a loss of normal hepatic architec­
ture, an usually prominent border between the nodule and 
surrounding parenchyma, and compression of surrounding 
hepatic parenchyma due to expansion. Several mitotic 
figures could usually be seen within nodules (Fig. 5).
The cellular makeup of these nodules tended to be 
heterogenous with mixtures of basophilic, acidophilic, 
clear, and tigroid cells. In many nodules, one cell type 
predominated, while in others an equal proportion 
of the various cell types could be observed.
Hepatic cell dysplasia was often marked in affected 
rats* livers, with more bizarre hepatocytes observed
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Fig. 3: TEM, hepatocytes with SER proliferation, CARC-PH, 
4weeks. 5600X Bar=lum
Fig. 4: Acidophilic/clear cell focus, liver. Arrowhead- 
SER, arrow-excess glycogen. HE. 20X
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than described for the four week sacrifice, and more irre­
gular sinusoidal spaces being formed. Some areas of dys­
plasia appeared to be contiguous with areas of early 
nodularity.
Biliary changes in these treated groups were compara­
tively mild. In some animals there were a few aggregates 
of biliary ducts with scant stroma resembling simple cho- 
langioma. Proliferation of bile ducts associated with 
surrounding proliferation of fibroblasts and deposition 
of fibrous connective tissue was noted infrequently.
Neoplastic nodules were not observed and altered 
hepatocytic foci were scarce in CARC-PB and CARC-eth rats. 
Microsopic findings in control animals in all groups 
included slight portal lymphoplasraacytic infitrates and 
slight periductular and ductular cell proliferation.
Kidney-Microscopic Examination:
No gross abnormalities were noted in the kidneys. 
However, a few kidneys from rats in the CARC-PH, CARC-AAN, 
and CARC-PB groups had foci of altered tubular epithelium 
(Fig 6). These altered foci were isolated proximal tubules 
lined by one or s e v e r a l  layers of e p i t h e l i a l  c e l l s  with 
enlarged oval, vesiculated nuclei and moderate to abundant 
amounts of a slightly basophilic cytoplasm. Tubules were 
e i t h e r  s o l i d  or c y s t i c  w i t h  l u m i n a  c o n t a i n i n g  a 
p r o t e i n a c e o u s  fluid. The e p i t h e l i a  s o m e t i m e s  p r o jected 





S e v e r a l  rats from a l l  the c a r c i n o g e n - t r e a t e d  and 
c o n t r o l  groups had m i l d  to m o d e r a t e  l e s i o n s  which were 
compatible with a mycoplasma etiology (see histological 
description for the four week sacrifice date). The 
pulmonary nodules in the one rat sacrificed due to dyspnea 
corresponded histologically to markedly ectatic 
bronchioles with lumina filled with neutrophilic 
infiltrates, sloughed epithelial cells, and cellular 
debris.
In addition,there were several CARC-PH and CARC-eth 
rats with a l v e o l a r  c e l l  h y p e r p l a s i a  u n a s s o c i a t e d  with 
m o n o c y t i c  septal i n f i l t r a t e s  (Fig.7). Th e s e  were few in 
number and w i d e l y  scattered. A l v e o l a r  lin i n g  c e l l s  were 
enlarged with more basophilic nuclei and moderate amounts 
ofa slightly basophilic or foamy cytoplasm. These cells 
would occur in single or multiple layers which protruded 
slightly into the a l veolar air space.Moderate numbers of 
a l v e o l a r  m a c r o p h a g e s  were pre s e n t  in a i r w a y s  within 
hyperplastic foci.
Other histologic lesions occured in cardiac muscle 
and were identical to those described previously.
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Fig. 5: Neoplastic nodule (N), liver. HE 20X




There was moderate to marked SER proliferation (Fig. 
8) with displacement of other cytoplasmic organelles into 
groups. Most of the h e p a t o c y t e s  examined had s l i g h t  to 
moderate variation in mitochondrial morphology. This 
variation was most noticeable in the ethanol group, where 
e l o n g a t e d  and ring forms were present (Fig. 9). 
Mitochondria in this group also contained focally 
dilations of the inner membrane as well as multiple 
densities within the matrix. Bile canaliculi were slightly 
to moderately dilated in most treatment groups and lined 
by variable-sized microvilli, some of which were 
shortened. There was slight to focally marked disruption 
of RER lamella. Nuclear changes included an increased 
prominence to the nucleolonema in some hepatocytes.
CONT (~PH,-AAN,-PB,-eth) rats:
There were no significant differences in ultrastruc- 
tural morphology between livers examined at this kill 
date and control livers described previously.
TWENTY-FOUR WEEK INTERVAL
During the time period between 16 and 24 weeks six 
animals died or were killed for humane reasons. Sever­
al of these rats observed in their cages days or weeks be-
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Fig. 7: Alveolar cell hyperplasia, lung. HE 20X
Fig. 8: TEM, hepatocyte, marked SER p r o l i f e r a t i o n .  CARC- 
AAN, 12 weeks 18,750X Bar=.5um 
M=mitochondria
fore n a t u r a l  death or being k i l l e d  had m a r k e d l y  pale 
mucous membranes, pale retinas, and very pale extremities. 
A few rats were simply found dead without premonitory 
signa. Others were discovered in a prone position with a 
markedly increased respiratory effort and were 
subsequently killed.
Gross examination of these rats revealed a 
similar pattern of observations: diffusely pale 
tissues, watery blood, slight to moderate peritoneal 
hemorrhage, moderately enlarged spleens, marked intra­
luminal hemorrhage throughout most of the gastrointesti­
nal tract, livers whose lobes contained multiple nodules 
or were enlarged, rounded and pale tan with multiple rela­
tively collapsed red-brown areas of parenchyma, a green- 
brown discoloration of the kidneys, and scattered moderate 
to severe intramuscular hemorrhage in various skeletal 
muscles. Hemoglobin and PCV values taken from one of the 
r a t s  b e f o r e  b e i n g  k i l l e d  w e r e  2.3 g m / d l  and 7.0%, 
respectively.
Not all rats that appeared "anemic" on external ob­
s e r v a t i o n  died s p o n t a neously. S e v e r a l  of these a n i m a l s  
survived and were killed at 24 weeks.
S e v e r a l  C A R C - A A N  rats d e v e l o p e d  rectal p r o l a p s e s  
wh i c h  o c c a s i o n a l l y  had to be treated, but for the most 
part, corrected themselves. This condition was exclusive 
to rats in this p a r t i c u l a r  group and was seen in rats up
to the final k i l l  date (36 weeks). This c o n d i t i o n  ne v e r  
specifically resulted in death, although it probably had 
a contributory effect on the generally poor condition of 
rats in this group thr o u g h o u t  the last months of the 
study.
Liver-Gross Examination:
Livers of carcinogen-treated rats at or before the 24 
week k i l l  date were a l l  affected, once again e x c e p t i n g  
those rats in the CARC-PB and CARC-eth groups (Table I). 
Rats in the CARC-PH had the most severely affected livers 
based on gross appearance and the number of rats so 
affected per group. The appearance of affected livers 
varied greatly. Some livers were essentially normal in 
size, color, and shape with on l y  a few 1-2 mm light tan 
nodules, whereas others were diffusely tan, with rounded 
lobes containing numerous 2-3 mm tan, yellow, or cream- 
colored spherical nodules scattered throughout, A few 
livers were so severely affected that only thin bands of 
red-brown parenchyma remained.
As expected, livers of rats dying during the interim 
were markedly nodular. Nodularity was often restricted to 
one or two lobes and other lobes were enlarged, rounded, 
pale tan or slightly yellow-green in color, and had a 
slightly irregular capsular surface. Close inspection of 
the capsular surface revealed .5 mm, irregular, nonraised
transluscent grey-green foci or dark red spherical foci 
of similar diameter in a multifocal distribution pattern.
On section, nodular or enlarged, rounded liver lobes 
often contained numerous neoplastic nodules, ranging in 
size fron .5 mm to 4 or 5 mm in diameter. These were tan 
to pale yellow, spherical, and usually well-demarcated 
from the surrounding parenchyma, which was usually mottled 
tan to red-brown. Larger nodules obviously compressed sur­
rounding parenchyma (Fig. 10).
Livers of CARC-PB and CARC-eth rats appeared re­
markably normal. No abnormalities were seen in livers from 
animals from any of the control groups [C0NT,-PH,-AAN,
- P B ,-eth ].
Kidney-Gross Examination:
Gross abnormalities were generally minimal, the 
green-brown discoloration of rats with the aforementioned 
hemorrhagic diathesis being the primary exception. One 
CARC rat and one CARC-AAN rat (Table IV) had 1-2 mm 
spherical, grey cortical foci, not at all visible from the 
capsular surface but readily observable on section (Fig. 
11). These were well-demarcated from the surrounding renal 
cortical tissue. No renal lesions were noted in controls.
Lung-Gross Examination:
Gross lesions were observed in all carcinogen-treated 
groups (Table VII) and consisted of multifocal .5-3 mm
51
Fig. 9: TEM, marked distortion of hepatic mitochondrial 
morphology. CARC-eth, 12weeks.
33.333X Bar=.5um
Fig. 10: Multiple neoplastic nodules (N), liver
TABLE IV Kidney, tumor numbers as a function
of time (kill interval)
Adenoma/CA # RMT @
1 2 3 4  T 1 2 3 4  T
CARC (24 rats) 0 0 0 1 1 0 0 0 1 1
CARC-PH (24 rats) 0 0 0 5 5 * 0 0 0 1 1
CARC-AAN (24 rats) 0 0 1 4 5 * 0 0 0 3 3
CARC-PB (24 rats) 0 0 0 2 2 0 0 0 0 0
CARC-eth (8 rats) 0 0 0 0 0 0 0 0 0 0
CONT (8 rats) 0 0 0 0 0 0 0 0 0 0
CONT-PH (8 rats) 0 0 0 0 0 0 0 0 0 0
CONT-AAN (8 rats) 0 0 0 0 0 0 0 0 0 0
CONT-PB (8 rats) 0 0 0 0 0 0 0 0 0 0
CONT-eth (8 rats) 0 0 0 0 0 0 0 0 0 0





# = significant difference in tumor no. means between
carcinogen and noncarcinogen groups (Duncan’s)
@ = no significant difference in tumor no. means be­
tween carcinogen and noncarcinogen groups (Duncan's)
* = significnatly increased tumor no. mean as compared
to CARC-eth, not to CARC and CARC-PB (Duncan’s)
TABLE V Statistical Evaluation: proximal convoluted 
tubule epithelial neoplasms
Source DF Mean Square Pr>F
liver/body wt. 1 0.20561228 0.0631
water 1 0.11561776 0.1622
treatment 4 0.13863932 0.0559
carcinogen 1 0.83026328 0.0003**
time 1 1.30816733 0.0001**
T*T 1 0.28527813 0.0290*
T*Carc 1 0.78845919 0.0004**
T*T*Carc 1 0.21783638 0.0558
Error 128 0.05849270













liver/body w t . 1 0.00568369 0.6652
water 1 0.01113857 0.5448
treatment 4 0.04247661 0.2358
carcinogen 1 0.12030576 0.0481*
time 1 0.37099911 0.0006**
T*T 1 0.06430987 0.1471
T*Carc 1 0.14991845 0.0277*
T*T*Carc 1 0.06133036 0.1567
Error 128 0.03021747





DF degrees of freedom
TABLE VII Lung, tumor numbers as a function
of time (kill interval)
Adenoma/CA # HES(met)
1 2 3 A T 1 2 3 A T
CARC (2A rats) 0 0 1 3 A 0 0 0 1 1
CARC-PH (2A rats) 0 0 0 A A 0 0 0 2 2
CARC-AAN (2A rats) 0 0 2 3 5 0 0 0 0 0
CARC-PB (2A rats) 0 0 1 2 3 0 0 0 0 0
CARC-eth (A rats) 0 0 1 1 2 0 0 0 0 0
CONT (8 rats) 0 0 0 0 0 0 0 0 0 0
CONT-PH (8 rats) 0 0 0 0 0 0 0 0 0 0
CONT-AAN (8 rats) 0 0 0 0 0 0 0 0 0 0
CONT-PB (8 rats) 0 0 0 0 0 0 0 0 0 0
CONT-eth (8 rats) 0 0 0 0 0 0 0 0 0 0




HES (met)=hemangioendothelial sarcoma metastases 
# = significant difference in tumor no. means between 
carcinogen and noncarcinogen groups (Duncan’s)
There was no significant difference in tumor no. means 
among the various carcinogen treated groups (Adenoma/CA) 
(Duncan’s)
TABLE VIII Statistical Evaluation: pulmonary epithelial
neoplasms
Source DF Mean Square Pr>F
liver/body wt. 1 0.61821324 0.0057**
water 1 0.01620022 0.6498
treatment 4 0.01087898 0.9675
carcinogen 1 1.40610384 0.0001**
time 1 2.09588303 0.0001**
T*T 1 0.19173699 0.1199
T*Carc 1 1.18395223 0.0002**
T*T*Carc 1 0.11690638 0.2238
Error 128 0.07822814




DF degrees of freedom
irregular nonraised or slightly-raised, grey-white or 
slightly transluscent areas scattered over the pleural 
surface and extending .5 mm into the parenchyma on 
section. These foci were primarily located at the 
periphery of all the lung lobes. The most extensive and 
invasive of these foci occured in the one rat killed from 
the CARC-eth group. This particular lesion was raised, 
-irregular, white, and extended greater than 1mm into the 
parenchyma. No pulmonary lesions were noted in control 
groups.
Liver-Microscopic Examination:
Hepatic lesions varied greatly in character and se­
verity, lesions were confined to treated rats, PB and 
ethanol rats had relatively minimally affected livers. 
Hepatic cell dysplasia was severe, especially in those 
rats which died of an apparent hemorrhagic diathesis. The 
number of altered foci was not striking, but the number of 
rats with neoplastic nodules had increased. The number of 
nodules varied between individual animals, from being 
few in number scattered throughout the parenchyma, to so 
numerous as to effectively replace the parenchyma in some 
lobes. Nodules varied greatly in size and in histological 
composition from one to the other. A noticeable difference 
was the increased number of nodules with focal areas along 
their borders where nodular hepatocytes became smaller and 
assumed a more chord-like arrangement which gave the ap-
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p ea r a n c e  of b l e n d i n g  into the s u r r o u n d i n g  p a r e n c h y m a  
rather than forming a sharp, c o m p r e s s i v e  border. W i t h i n  
o c c a s i o n a l  nodules, there were cystic foci formed by 
s p i n d l e  c e l l s  with elongated, w e b - l i k e  c y t o p l a s m i c  
projections. Cystic spaces often con t a i n e d  a f l o c c u l a n t  
eosinophilic material.
Biliary alterations had increased in severity in the 
above-mentioned treatment groups since the 12 week sacri­
fice. Biliary ductular cell and periductular cell proli­
feration was generally more marked. Increased numbers of 
rats had simple and/or cystic cholangioma. Cystic chol- 
angioma were typified by groups of dilated bile ducts 
containing no intraluminal mucus and lined by a flattened 
cuboidal epithelium(Fig. 12). They were surrounded by a 
scant fibrous stroma, which is more generous than that ob­
served in simple cholangioma. Cholangiofibrosis was also 
more common. This was a proliferation of ducts lined by 
cuboidal to columnar epithelial cells exhibiting intesti­
nal metaplasia with the secretion of mucous substances and 
surrounded by moderate to marked fibrous connective tissue 
reaction, often a c c o m p a n i e d  by m o d e r a t e  i n f i l t r a t e s  of 
lymphocytes and plasma cells(Fig. 13).
C A R C - P B  and CA R C - e t h  rats had a few hepatic l e s i o n s  
such as several foci of altered hepatocytes and some mild 
biliary changes. No neoplastic nodules were noted.
Lesions in control rats included slight, multifocal
lymphoplasmacytic portal infiltrates and occasional peri- 
ductular cell proliferation. A CONT-AAN rat had slight 
bile duct proliferation and associated slight periductular 
fibrosis.
Kidney-Microscopic Examination:
The number of c a r c i n o g e n - t r e a t e d  rats with alt e r e d  
p r o x i m a l  t u b u l e s  increased from those seen at 12 weeks. 
These were h i s t o l o g i c a l l y  i d e n t i c a l  to those des c r i b e d  
previously, and were not seen in CARC-PB or CARC-eth rats.
The two grossly visible cortical foci consisted of 
closely-packed, solid acini made up of cells with fairly 
uniform, round to oval nuclei with a single nucleolus 
and abundant amounts of a finely granular eosinophilic or 
s l i g h t l y  b a s o p h i l i c  c y t o p 1 asm(Fig.l4). These tub u l a r  
a g g r e g a t e s  were not e n c a p s u l a t e d ,  but they were w e l l -  
d e m arcated from the rest of the c o r t i c a l  tissue. No 
evidence of invasive tendencies was seen along borders of 
these masses although there was obvious compression of the 
s u r r o u n d i n g  c o r t i c a l  tissue. The mi t o t i c  index of these 
a l t e r e d  c e l l s  was quite high, one to two m i t o t i c 'figures 
could be observed per high power field, and some of these 
appeared bizarre in nature.
Microscopic lesions in control animals consisted of 
infrequent groups of dilated tubules lined by a flattened 
epithelium and filled with a proteinaceous material.
Fig. 12: Cystic cholangioma, liver. HE 20X 
Fig. 13: Cholangiofibrosis, liver. HE 20X
Lung-Microscopic Examination:
The m ajority of c a r c i n o g e n - t r e a t e d  rats ex h i b i t e d  
multiple areas of alveolar cell hyperplasia. These often 
i n v o l v e d  fa i r l y  e x t e n s i v e  regions of the p u l m o n a r y  
parenchyma and multiple layers of alveolar cells protruded 
into the alveolar airways.
Several rats had focal or multifocal solid areas of 
increased cellularity which obliterated the underlying 
alveolar architecture, were well-demarcated from the 
surrounding tissue, and which slightly compressed sur­
rounding alveolar airways resulting in their collapse. 
These were classified as alveolar/bronchiolar adenomas 
(Fig. 15). Neoplastic cells were arranged in either glan­
dular, papillary, or solidly cellular patterns on a scant 
connective tissue stroma. Cells were cuboidal to columnar 
with round to oval, vesiculated nuclei with a delicately 
stippled chromatin pattern. The cytoplasm was moderate to 
abundant in amount and was slightly granular and eosino­
philic to slighty basophilic. Between 0 to 1 mitotic fi­
gure was observed per high power field. Adenomas were 
sometimes contiguous with regions of alveolar cell hyper­
plasia .
The CARC-eth rat killed at this time, in addition to 
areas of hyperplasia and several adenomas, had malignant 
e p i t h e l i a l  tumors in the lung (Fig.16). These tumors 
were generally larger in size than the adenomas and
had prominently invasive borders as well as exhibiting 
mild compression of adjacent parenchyma. These tumors as 
well as the adenomas tended to occur at the periphery of 
the lung lobes. Neoplastic cells tended to form more solid 
arrangements and exhibited marked degrees of both cellular 
and nuclear pleomorphism, often with indeterminant cell 
borders. Cytoplasmic vacuolization and a general "foamy” 
a p p e a r a n c e  to the c y t o p l a s m  was striking in most tumor 
cells. N u c l e i  were more v e s i c u l a r  in a p p e a r a n c e  as 
compared with the benign neoplastic cells and there were 
an increased number of mitotic figures. Multiple areas of 
necrosis and mineralization were noted in these tumors as 
well as occasional focal areas of squamous metaplasia(Fig. 
17). Individual acini or solid cellular groups tended to 
elicit a more marked fibrous connective tissue reaction 
than was noted in any of the adenomas.
No pulmonary histological lesions were seen in CONT 
(-PH,-AAN,-PB,-eth) rats. Previous lesions compatible with 
mycoplasmosis seen in rats killed earlier in the study 
were not prominent in the rats killed at 24 weeks.
Other m i c r o s c o p i c  l e s i o n s  i n c l u d e  the o c c a s i o n a l  
monocytic interstitial infiltrates in the cardiac muscle 
of both carcinogen-treated and control rats. These 
infiltrates resulted in minimal focal loss of cardiac rayo- 
fibers. The macroscopic splenic enlargement observed in 
rats exhibiting signs of blood loss and anemia was due to
marked extramedullary hematopoiesis histologically.
Liver-Ultrastructural Examination:
CARC (-PH,-AAN,-PB,-eth): (Figs. 18,19,20,21)
Ultrastructural findings mirrored those seen at 12 
weeks, particularly the SER proliferation, disruption of 
RER, marked variability in mitochondrial morphology, and 
dilation and irregularity of bile canaliculi. In addition, 
the microvilli lining the sinusoidal borders were often of 
variable shape and length, resulting in a rather distorted 
appearance. Many hepatocytes examined had moderate numbers 
of c y t o p l a s m i c  v a c u o l e s  c o n t a i n i n g  s l i g h t  to mod e r a t e  
amountsof a granular or flocculant osmiophilic material. 
N u c l e a r  c hanges i n c l u d e d  a s l i g h t  i r r e g u l a r i t y  to the 
n u c l e a r  m e m b r a n e  and an i n c r e a s e d  p r o m i n e n c e  to the 
nu c 1 e o 1onema. CARC-PB rats generally had fewer regions of 
disorganized lamella of RER and bile canaliculi appeared 
nonremarkable.
CONT (-PH,-AAN,-PB,-eth) Rats:
Hepatocytes examined from controls were normal except 
for a CONT-AAN rat which had focal regions of moderate to 
marked variability in mitochondrial morphology.
THIRTY-SIX WEEK INTERVAL
Eight c a r c i n o g e n - t r e a t e d  rats either died or were 
sac r i f i c e d  due to e x t r e m e l y  poor c o n d i t i o n  be t w e e n  30
Fig. 14: Adenoma, kidney. HE 20X
Fig. 15: Alveolar/bronchiolar adenoma, lung. HE 20x
Fig. 16: Alveolar/bronchiolar carcinoma, lung. HE 20X
Fig. 17: Alveolar/bronchiolar carcinoma, lung. Areas of 
squamous metaplasia (arrowheads), HE 20X
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Fig. 18: TEM, hepatocyte. CARC-PB, 24weeks. SER
proliferation, disorganized RER, irregular 
nuclear shape, variable mitochondrial morphology, 
cytoplasmic vacuoles. 5850X Bar=lum
Fig. 19: TEM, hepatocyte. CARC-PB, 24weeks. SER
proliferation, disorganized RER, irregular 
nuclear shape, variable mitochondrial morphology, 
cytoplasmic vacuoles. 7350X Bar-lum
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Fig. 20: TEM, hepatocyte. CARC-AAN, 24weeks. Nu­
merous cytoplasmic vacuoles; dilated bile canal­
iculus (arrowheads). 9062X Bar=lum
Fig. 21: TEM, hepatocyte. CARC-AAN, 24weeks. Ir­
regular microvilli lining sinusoidal border 
(arrowhead). 11,850X Bar=lura
weeks and the final k i l l  date of 36 weeks. Two a n i m a l s  
died with a grossly evident hemorrhagic diathesis into the 
g a s t r o i n t e s t i n a l  tract lumen as w e l l  as emaciation. A 
C A R C - P H  rat had marked heraoperitoneum a s s o c i a t e d  with a 
2.5x3 cm hematoma originating from a necrotic liver 
lobule. This was covered with a yellow-tan irregular 
material which adhered to the lesser curvature of the 
stomach, spleen, pancreas, and duodenum and which appeared 
contiguous with the necrotic hepatic parenchyma. Another 
rat (CARC-AAN) also died from severe intra-abdominal 
hemorrhage, this time associated with a renal mass. A 
CARC-AAN rat was killed due to progressive emaciation as a 
result of severe incisor overgrowth. Two rats (CARC-AAN 
and CARC-PH) were killed because of marked emaciation 
associated with severe hepatic lesions. One rat (CARC-AAN) 
was found dead with no significant gross lesions evident 
on necropsy.
Liver-Gross Examination:
All the rats in the CARC and CARC-PH groups had 
multiple neoplastic nodules. In contrast, only half of the 
C A R C - A A N  rats had g r o s s l y  n o d u l a r  livers. C A R C - P B  and 
CARC-eth rats were free of any gross hepatic 
abnormalities (Table I).
N o d u l a r i t y  in a f f e c t e d  l i v e r s  varied from s u b t l e  
s urface i r r e g u l a r i t y  to dis c r e t e  s p h e r i c a l  n o d u l e  
formation. Neoplastic nodules were lighter than the normal
l i v e r  in co l o r  and varied in size from 2 mm up to 1 or 2 
era in diameter. Many were generally spherical in shape, 
whereas others were irregular. Some nodules were well- 
delineated from surrounding parenchyma and others had 
finger-like projections which enmeshed or blended into 
the adjacent parenchyma. Many neoplastic nodules were 
confluent and formed plaque-like growths on the capsular 
surface with slightly urabilicated centers (Figs. 22,23), 
These nodules on section often had multiple, white firm 
regions as well as scattered hemorrhagic or green-brown 
areas. The remnants of normal parenchyma in these nodular 
livers appeared as irregular bands of tissue. In some 
rats, lobes were less nodular but were enlarged, tan, and 
rounded with several discrete transluscent grey or yellow- 
green, nonraised irregular 1-2 mm foci on the capsular 
surface. l-2mm spherical or irregular, dark red, slightly 
raised foci were also noted on the capsular surface of 
some rat livers. One C A R C - P H  rat had an i r r e g u l a r  5 to 6 
mm in diameter, collapsed focus on the left lateral liver 
lobe (Fig. 24). On section, this was associated with a 
group of closely-packed, cystic structures which contained 
a serosanguineous fluid.
No gross hepatic lesions were noted in control rats 
[CONT,-PH,-AAn,-PB,-eth].
Fig. 22: Nodular liver. AP + nitrite, 36weeks. 
Fig. 23: Nodular liver. AP + nitrite, 36weeks.
Kidney-Gross Examination:
Renal neoplasms consisted of benign and malignant 
cortical epithelial tumors as well as malignant 
mesenchymal tumors. Renal cortical adenomas have been 
previously described. They were particularly numerous at 
this kill date in the CARC-PH and CARC-AAN groups (Table 
IV).
Tumors classified as adenocarcinomas were less com­
mon. They were easily visualized as bulging nodular 
masses, l-2cm in diameter, that were pink to grey, fleshy 
and spherical with a well-vascularized surface (Fig. 25). 
On section these masses extended into the cortical renal 
tissue, but did not extend into the m e d u l l a r y  region. 
There was a sharp demarcation between neoplastic and 
normal cortical tissue with obvious compression of sur­
rounding tissue.
Renal tumors classified as renal mesenchymal tumors 
were strikingly different in appearance. One rat had a 
3x4 cm, yellow mass with a somewhat fatty consistency 
p r o t r u d i n g  from the caudal p o l e  of its left kidney. A 
focal area of hemorrhage near the tumor's base was 
the apparent source of the fatal hemoperitoneum which was 
the cause of this animal's demise. On section, this neo­
plasm was yellow-tan to grey-tan in color, and extended to 
the renal pelvis (Fig. 26).
In other rats with renal mesenchymal tumors (RMT),
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Fig. 24: HES, liver (arrowhead). CARC, 36weeks.
Fig. 25: Renal adenocarcinoma (RAC).
CARC-PH, 36 weeks.
the tumors were not readily visible on the cortical 
surface but presented on section as irregular grey-white 
masses within the cortex or medullary regions with 
prominent cystic structures and irregular, poorly defined 
borders (Fig. 27). A particular variation on this theme 
was a tumor within the c o r t i c a l  region of one rat which 
consisted of a 2-3 mm cyst filled with a serosanguineous 
fluid, somewhat reminiscent of the cystic, hemorrhagic 
tumors seen in the liver.
Malignant epithelial and mesenchymal tumors could co­
exist within the same kidney. No gross abnormalities, were 
noted in the kidneys from control rats.
Lung-Gross Examination:
S e v e r a l  rats from each c a r c i n o g e n - t r e a t e d  group, 
including the CARC-PB and CARC-eth groups, had multiple, 
.5-2 mm, grey to white, nonraised or slightly raised, firm 
foci scattered throughout the various lung lobes (Table 
VII). These extended into the pulmonary parenchyma on 
section. In the three carcinogen-treated groups other than 
the PB and ethanol groups, larger pulmonary masses, up to 
1 cm in diameter, were noted in va r i o u s  lung lobes, 
usually involving peripheral areas. These masses were 
irregular, solid, grey to white with a mottled pattern on 
cut surfaces. They extended up to 5-7 mm into the lung 
parenchyma (Fig. 28).
Several rats with hepatic hemangioendothelial sarco-
Fig.
Fig.
26: Renal mesenchymal tumor (RMT). Normal kidney on 
left. CARC-AAN, 32weeks.
27: Renal mesenchymal tumor. Cystic cavities (cc); 
i r r e g u l a r , i n f i l t r a t i v e b o r d e r  (ib)
mas (HES), had multiple 1-3 mm, spherica1,-s 1 ight1 y 
raised, dark red-brown foci scattered throughout the lung 
lobes in no particular pattern, suggesting a blood-borne 
metastatic mechanism.
No specific pulmonary abnormalities were seen in con­
trol rats [CONT,-PH,-AAN,-PB,-eth].
Liver-Microscopic Examination:
The CARC, CARC-PH, and CARC-AAN groups had severely 
affected livers, while CARC-PB and CARC-eth rats had 
relatively mild hepatic lesions. Severely affected 
carcinogen-treated rats had multifocal to coalescing 
neoplastic nodules, some of which had sharp borders and 
others which blended or extended into the surrounding 
parenchyma. Most well-delineated neoplastic nodules 
consisted of hepatocytes with abundant eosinophilic 
cytoplasm and marked nuclear pleomorphism with 
occasional intranuclear cytoplasmic inclusions. Focal 
areas of nodules or entire nodules consisted of compara­
tively well-differentiated hepatocytes with moderately 
pleomorphic round nuclei, and moderate to abundant amounts 
of an eosinophilic cytoplasm. These cells were arranged in 
trabeculae three or four cell layers thick and formed si­
nusoidal spaces containing an edematous fluid, or formed 
occasional glandular structures. No normal hepatic archi­
tectural arrangement was noted in these tumors. These 
latter neoplasms resembled hepatocellular carcinomas in
Fig. 28: Alveolar/bronchiolar carcinoma (arrowhead), 
tral surface, lung. CARC-AAN, 36weeks.
ven-
some respects, with a primarily trabecular pattern, and 
seemed to be of a more aggressive nature than the typical 
nodules, as their borders were not well-defined, and they 
seemed to extend into the surrounding parenchyma in a man­
ner which suggested infiltration, rather than a remodeling 
attempt. They also proliferated and expanded beneath the 
capsular surface, but never overtly invaded blood vessels, 
lymphatics, or extended through the hepatic capsule.
Four c a r c i n o g e n - t r e a t e d  rats(3 CAR C - P H  rats,lCARC 
rat) (Table.I) had neoplasms derived from hepatic 
endothelial cells, namely hemangioendothelial sarcomas. 
These neoplastic cells usually lined blood-filled, 
vascular spaces in one or multiple layers (Fig. 29). 
Neoplastic endothelial cells were pleomorphic, roughly 
angulate or spindle-shaped, with markedly pleomorphic oval 
nuclei with one to several enlarged nucleoli and often 
abundant, granular eosinophilic cytoplasm. A lighter 
eosinophilic zone was often seen adjacent to the nucleus 
with a darker, more basophilic cytoplasm restricted to the 
cell periphery. One to three bizarre mitotic figures were 
noted per high power field. C e l l s  were a r ranged on a 
fibrous stroma, and often surrounded groups or chords of 
hepatocytes. Focally extensive areas of fibrosis extended 
from these endothelial masses, encompassing hepatocytes 
and biliary structures, resulting in effacement of the 
normal architecture.
One of these tumors originated from an essentially 
necrotic hepatic lobe, and formed the borders of a 2x3 cm 
abdominal hematoma which was described in the gross exam­
ination section. Neoplastic cells forming this border 
were less angulate, and more spindleloid in nature and 
exhibited multiple attempts at vessel formation. Occa­
sional cells had prominent lightly eosinophilic cyto­
plasmic zones. These spindle cells formed vascular ar­
rangements parallel to the serosal surface of the duode­
num and extended along fascial planes into the muscular 
tunics.
Lesions derived from biliary ducts were common and 
often extensive in carcinogen-treated rats, but were 
generally absent in the CARC-PB and CARC-eth groups. Com­
mon biliary lesions included ductular and periductular 
cell proliferation, simple and cystic cholangiomata, and 
cholangiofibrosis. One rat had a biliary abnormality re­
sembling the benign biliary neoplasm, cholangiofibroma. 
This structure consisted of multiple bile ducts exhibiting 
intestinal metaplasia surrounded by extensive fibrosis and 
fibroplasia which tended to compress the surrounding hepa­
tic parenchyma. The center of this mass consisted mostly 
of fibrous connective tissue, scant biliary structures, 
and moderate to severe lymphoplasmacytic infiltrates.
Additional hepatic lesions in treated rats consisted 
of focal areas of dilated, blood-filled sinusoidal spaces
and the sponge-like formations, filled with a flocculant 
eosinophilic material, as described at the 24 week inter­
val .
CARC-PB and CARC-eth rats had mild liver lesions 
c o n s i s t i n g  of a l t e r e d  foci,mild b i l i a r y  p r o l i f e r a t i o n ,  
infrequent simple and cystic cholangiomata and cholangio- 
fibrosis, but conspicuously lacking in neoplastic nodules.
One CONT-PH rat had a hepatic lesion resembling an 
altered focus. This was made up of hepatocytes of the eo­
sinophilic and clear cell varieties, with some fat-con­
taining hepatocytes noted as well. This was actually an 
area affected, not a focus, as it approximated several he­
patic lobules in diameter. There was not an obvious border 
as seen in nodules, and no compression of adjacent hepato­
cytes. No other hepatic abnormalities were noted in con­
trol groups.
Kidney-Microscopic Examination:
Malignant neoplasms derived from tubular epithelial 
cells consisted of neoplastic cells in the following ar­
rangements: solid trabeculae, acini with focal cystic 
areas, and papillary formations. Neoplastic cells con­
tained moderately pleomorphic, round to oval vesiculated 
nuclei with one or two nucleoli and moderate to abundant 
amounts of an eosinophilic to lightly basophilic, granu­
lar, foamy, or vacuolated cytoplasm. Cell borders were 
sometimes difficult to delineate when cells were arranged
in solid trabecular patterns, but when lining cystic, 
fluid-filled spaces on papillary projections, neoplastic 
cells were cuboidal to columnar. Mitotic fiqures were fre­
quent (2-4 per high power field) and multifocal necrotic 
regions could be observed within tumor masses. Stroina was 
generally scant. Tumors lacked a definitive fibrous 
capsule, but were we 1 1 - d e 1 ineated from surrounding 
cortical tissue, which was markedly compressed 
due to tumor expansion (Fig. 30). No evidence of invasion 
along the tumor borders was observed. Areas of the neo­
plasm expanded beneath the kidney capsule, but did not ex­
tend through it.
There was a particular adenocarcinoma with a more pa­
pillary pattern of arrangement in one CARC-PB rat. 
Tubules were lined by multiple layers of neoplastic 
tubular cells which formed papillary projections into 
lumina filled with a proteinaceous fluid, sloughed tubular 
cells, or necrotic debris. The percentage of neoplastic 
cells with prominent cytoplasmic clear vacuoles was 
strikingly increased.
Renal m e s e n c h y m a l  tumors were made up of s p i n d l e  
cells arranged in solid sheet-like formations with scat­
tered, small vascular clefts and spaces with no 
discernible endothelium (Fig. 31). Spindle cells had 
fusiform, moderately pleomorphic, oval to fusiform 
basophilic nuclei with indeterminant amounts of an
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Fig. 29: Hemangioendothelial sarcoma, liver. Neoplastic
endothelial cells (arrowheads) line blood-filled 
spaces. HE 20X
Fig. 30: Renal adenocarcinoma (RAC), solid trabecular.
HE 20X
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eosinophilic cytoplasm. Mitotic activity was not 
particularly prevalent. In other regions within the same 
tumor, neoplastic cells assumed a more stellate 
appearance, with elongated cytoplasmic processes, and were 
arranged in a loose, slightly basophilic mesenchymal 
matrix. At neoplastic borders, spindle cells 
infiltrated along the interstitium and formed whorling 
arrangements around sequestered tubular structures (Fig. 
32). Such incorporated tubules were occasionally cystic, 
and lined by a flattened epithelium.
There was one RMT (CARC-AAN) with an exclusively 
vascular differentiation. This was a cystic cavity 
involving the cortex and medulla, the periphery of which 
was made up of anastomosing pegs of fibrous connective 
tissue containing incorporated renal tubules, and lined by 
flattened, moderately pleomorphic endothelial cells. Spaces 
formed by these anastomosing branches contained mixtures 
of erythrocytes, macrophages exhibiting erythrophagocyto- 
sis, and immature cells of the erythroid series.
Lung-Microscopic Examination:
Areas of alveolar cell hyperplasia were observed in 
all treated rats. Regions of hyperplasia, adenoma, and 
adenocarcinoma were classified according to the histo­
logic criteria discussed for the 24 week interval and 
will not be repeated.




Fig. 31: Renal mesenchymal tumor. Spindle cells occur in
sheets or line occasional vascular spaces (arrow­
heads) HE 20X
Fig. 32: R M T .Border,with sequestered tubules (st) HE 20X
rat that was not seen elsewhere In the study. This tumor 
not only had prominent areas of squamous metaplasia but 
also had irregular, sometimes cystic glandular structures 
lined by flattened cuboidal to columnar epithelium and 
contained an intraluminal amorphous, basophilic material. 
There was a moderate to marked scirrhous response 
separating these glandular structures.
Metastatic hepatic hemangioendothelial sarcomas with­
in the lungs retained the individual cellular morphology 
of the primary neoplasm and, when large enough, also 
formed prominent blood-filled spaces. Alveolar airways 
surrounding these metastatic sites contained hemorrhage 
and pulmonary macrophages exhibiting erythrophagocytosis 
and/or hemosiderosis. Small intravascular tumor emboli 
were also noted of identical cell types (Fig.33). These 
were usually solid and focal invasion of tumor cells 
through the vessel wall could be appreciated.
In various control and carcinogen-treated rats, focal 
areas of degeneration with or without fibrosis were seen 
involving cardiac myofibers. Slight interstitial 
mononuclear infiltrates and proliferation of myonuclei 
were also noted within these areas. No other significant 
lesions occured in tissues examined from control rats.
Liver-Ultrastructural Examination:
CARC [-PH,-AAN,-PB-eth] Rats: Because of the variation 
between treatment groups, ultrastructural hepatocytic
findings will be discussed separately for each group.
CARC:
Hepatocytes examined were along a fibrotic borderof 
a neoplastic nodule (Fig. 34). The hepatocytes were 
irregular in shape with markedly irregular nuclei (Fig. 
35). The cytoplasm was relatively scant in amounts, and 
there was a paucity of cellular organelles. Mitochondria 
were small and elongated. Moderately dilated profiles of 
RER formed branching and anastomosing channels throughout 
the cytoplasm, connecting with a prominent perinuclear 
space. Intercellular space was increased. Cellular borders 
were lined by irregular, thin, varying numbers of 
microvilli. Bile canalicular structures were formed at 
numerous junctions between and among hepatocytes. These 
were irregular, dilated and lined by varying numbers of 
blunted or elongated microvilli. In one canaliculus was 
observed a ciliura with a prominent basal body lining the 
luminal space along with the microvilli (Fig. 36). 
Occasional cytoplasmic blebs were seen within canalicular 
lumina (Fig. 37).
CARC-PH: (Figs. 39,40,41)
There was marked variation in hepatocytic shape and 
in the amount of cytoplasm. Hepatocytes had round, oval, 
or irregular nuclei usually with a nucleolonema of 
increased prominence. Multiple areas of scant aggregates
Fig. 33: Hemangioendothelial sarcoma (HES), intravascular 
metastatic focus, lung. HE 20X
of SER were noted in some c e l l s  w h i l e  others had few 
organelles. Profiles of disorganized RER with free 
ribosomes and RER with moderately dilated cisternae were 
common. There was moderate to marked variability in 
mitochondrial morphology, many were small and elongated. 
Haphazardly arranged bundles of filaments were noted 
around markedly dilated and irregular canaliculi (Figs. 
39,40) .
CARC-AAN:
Hepatocytes were not significantly different from 
those observed at 24 weeks.
CARC-PB:
Hepatocytes had slight to moderate variation in mito­
chondrial morphology, slight to moderate aggregates of SER 
proliferation, slight disruption of stacks of RER, and 
essentially normal bile canaliculi (Fig. 43).
CARC-eth:
Hepatocytes examined were essentially normal, with 
a few lipid vacuoles.
CONT [-PH,-AAN,-PB,-eth] Rats:
Hepatocytes were nonremarkable, excepting PB rats. 
Hepatocytes from rats in this group revealed marked SER 
proliferation which was severe enough to displace the 
nucleus and cytoplasmic organelles toward one pole of
Fig. 34: TEM, hepatocytes (h), border of neoplastic 
nodule. CARC, 36weeks. 4429X Bar=lutn
Fig. 35: TEM, hepatocyte. CARC, 36weeks. 9152X 
Bar=lum
Fig. 36: TEM, Bile canaliculus lined by microvilli and 
one cilium (arrowhead) with a prominent basal 
body. CARC, 36weeks. 30.000X Bar=.5um
Fig. 37: TEM, bile canaliculus, cytoplasmic projection. 
CARC, 36weeks. 18,056X Bar=.5um
Fig. 38: TEM, hepatocytes form enlarged biliary space,
surrounded by basement membrane. 11,119X Bar=.5um 
C A R C , 36 we e k s .
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Fig. 39: TEM, hepatocytes, bile canaliculus (be). 
CARC-PH, 36weeks. 7750X Bar=lum
Fig. 40: TEM, bile canaliculus,junctional complexes, 
cytoplasmic filaments. 53.333X Bar=.lum 
CARC-PH, 36 weeks.
Fig, 41: TEM, a less affected hepatocyte. CARC-PH, 
36weeks. Areas of SER proliferation.
5400X Bar=lum
the cell (Fig. 42). This was not a uniform change in 
all hepatocytes, as cells lacking this obvious SER 
proliferation were noted as well. Some PB rats also had 
several to numerous cytoplasmic fat vacuoles.
Liver-Hemangioendothelial Sarcomas:
Neoplastic cells were elongated or spindle-shaped, 
with a cytoplasm of rather high density. Nuclei were 
markedly irregular in shape, had peripherally condensed 
chromatin material, and had one or two nucleoli with 
prominent, dense nucleolonema. Numerous free mitochondria 
were noted in the cytoplasmic ground substance. Neoplastic 
cells were invested with a network of RER, the cisterna 
of which was moderately dilated with a finely granular ma­
terial (Fig. 44). A few mitochondria were seen. Some cells 
contained several lipid vacuoles or irregular vacuoles 
of a dark-staining material mixed with cellular debris 
(Fig. 45). Bundles of intermediate filaments were 
prominent beneath the plasma membrane or formed wavy 
aggregates within the cytoplasm(Fig. 46). Small, dense 
oblong membrane-bound bodies were occasionally noted in 
the cytoplasm of tumor cells. The plasma membrane was 
irregular and contained small bleb-like projections. Few 
cytoplasmic vesicles were noted beneath the plasma 
membrane. Neoplastic cells were connected to each other by 
structures resembling tight junctions, but were often 
separated by wide intercellular spaces containing some
Fig. 42: TEM, hepatocyte, marked SER proliferation. 
CONT-PB, 36weeks. 7995X Bar=lum
Fig. 43: TEM, hepatocyte, CARC-PB, 36week's.
Relatively mild ultrastructural alterations. 
7 313X Bar = 1um
collagen fibrils and a granular or fibrillar debris. In 




Neoplastic cells were arranged into acini (Fig. 48) 
on a split basement membrane. Spindle-shaped cells with 
o v a l  or i r r e g u l a r , e l o n g a t e d  nuc l e i  and a c y t o p l a s m i c  
network of moderately dilated RER were seen surrounding 
acini, positioned among layers of the basement membrane. 
Adenocarcinoma cells had a prominent brush border orien­
tated towards a luminal surface, although occasional dis­
placed segments of brush border were observed along later­
al cell boundaries (Fig, 49). Invaginations of microvilli 
along the luminal surface were occasionally observed 
within the cytoplasm of carcinoma cells (Fig. 50). Cells 
had a rather dense c y t o p l a s m  with few or a m o d e r a t e  number 
of oval or elongated mitochondria, a few profiles of RER, 
numerous free ribosomes, and profiles of prominently 
dilated golgi (Fig. 51). Nuclei were oval to indented and 
irregular in shape, with a prominent nucleolonema. Lateral 
cellular interdigitations were prominent and junctional 
complexes were noted between cells at the brush border 
(Fig. 52). Infoldings of the basilar plasma membrane were 
tortuous.
Fig. 44: TEM, hemangioendothelial sarcoma, liver. 18.243X 
Bar=.5um
Fig. 45: TEM, hemangioendothelial sarcoma, liver. Cyto­
plasmic vacuoles (arrowheads). 9743X Bar=lum
46: TEM, hemangioendothelial sarcoma, liver. Bundles 
of vimentin filaments (IFs). 100,000X Bar=.lum
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Fig. 47: TEM, hemangioendothelial sarcoma, liver. Vascular 
clefts (VC). 7313X Bar=lum
Renal Mesenchymal Tumor:
Neoplastic mesenchymal cells contained oval or irre­
gular and somewhat fusiform nuclei. Heterochromatin was 
dispersed in clumps throughout the nucleus or peripheral­
ly localized. The nucleolonema in many cells was prominent 
and enlarged. Cells assumed an elongated or spindle shape, 
although cell borders were difficult to distinguish. There 
was variation in cytoplasmic density, less dense cells of­
ten exhibited wide separation of organelles by free space. 
The c y t o p l a s m  contained a few m i t o c h o n d r i a  with marked 
morphological variation and prominently dilated RER (Fig. 
53). Dilated RER cisternae contained a flocculant or 
finely granular material. 'Free ribosomes were also noted. 
Groups of microfilaments formed multifocal densities with- 
in the cytoplasm (Fig. 54). Cells were arranged as sheets 
orformed c l e f t s  or spaces c o n t a i n i n g  e r y t h r o c y t e s  (Fig. 
55). A granular or flocculant material was noted adjacent 
to the plasma membrane of those cells forming vascular 
clefts. Definitive cell junctions were difficult to dis­
cern, however, focal densities along the plasma membranes 
of adjacent tumor cells corresponded to tight junctions.
Lung-Ultrastructural Examination:
Alveolar Cell Hyperplasia:
These foci consisted of multiple layers of type II 
pneumocytes with moderate numbers of osmiophilic
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Fig. 48: TEM, renal adenocarcinoma. 5355X Bar=lum 
CA=carcinoma cells; I=interstitium
Fig. 49: TEM, renal adenocarcinoma. Prominent brush bor­
der (BB). 9920X Bar=lurn
Fig. 50: TEM, renal adenocarcinoma. Intracytoplasmic 
invaginated microvilli (arrowheads). 4A,978X 
Bar=,1 urn
Fig. 51: TEM, renal adenocarcinoma. Dilated golgi (G), 
12,811X Bar=lum
Fig. 52: TEM, renal adenocarcinoma. Junctional complexes 
(jc). 1 2 fl62X Bar=lum
lamellated bodies within the-cytoplasm (Fig. 56). Luminal 
surfaces of these cells had numerous blunt microvilli and 
a few bleb-like cytoplasmic projections (Fig. 57). Cells 
rested on a thickened basement membrane.
Pulmonary Adenocarcinoma:
Neoplastic cells making up the carcinomas contained 
variable amounts of a dense cytoplasm with multiple, 
short profiles of slightly to moderately dilated RER, nu­
merous polyribosomes, and moderate numbers of elongated 
mitochondria. Variable numbers of cytoplasmic vacuoles 
containing a lamellated osmiophilic material were seen 
in most tumor cells (Figs. 58,59), especially in apical 
regions of the cell. These vacuoles were variable in shape 
and diameter. The apical surface was occupied by numerous, 
well-developed microvilli, which were uniform in size and 
shape, and by occasional cytoplasmic blebs. Nuclear mor­
phology varied; some nuclei were oval while others were 
markedly irregular. Heterochromatin was usually condensed 
at the n u c l e a r  membrane and the n u c l e o l u s  was e n l a r g e d  
with a prominent nucleolonema. Lateral cell borders ex­
hibited markedly tortuous interdigitations with focal 
junctional structures. Most well-formed junctional 
complexes, however, were located at the apical 
borders between cells. Bundles of cytoplasmic filaments 
formed focal densities beneath the rows of microvilli. 
Neoplastic cells were usually arranged into acini on a
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Fig. 53: TEM, renal mesenchymal tumor. 4340X Bar=lum
Fig. 54: TEM, renal mesenchymal tumor. Focal densities of 
cytoplasmic microfilaments (arrowheads). 67,500X 
Bar=.1um
Ill
Fig. 55: TEM, renal mesenchymal tumor. Neoplastic cells 
form vascular clefts. 4857X Bar=lum
tortuous basement membrane (Fig. 60). Collagen fibrils 
separated acini. Acini luminal spaces often contained 
variable amounts of free lamellated osmiophilic material, 
which was occasionally seen to be engulfed by intraluminal 
pulmonary macrophages.
Statistical Evaluation:
Tables I through XII list tumor numbers (Tables 
I,IV,VII) as well as statistical evaluation of the various 
tumor types (Tables II,III,V,VI,VII[), water consumption 
(Tables XI,XII) and liver weight as a percentage of total 
body weight (Tables IX,X). For hepatocytic tumors there 
was a highly significant (P<.01) negative correlation 
between the intake of phenobarbital(1.75% ethanol) and the 
number of such tumors. For renal adenomas and 
adenocarcinomas there was a significant (P<.05) positive 
correlation between the experimental manipulation and the 
appearance of these tumors in the CARC-PH and CARC-AAN 
groups. For pulmonary epithelial tumors no such 
significant positive correlation was evident as a function 
of treatment group. For hemangioendothe1 ia1 sarcomas, 
there was a highly significant (P<.01) positive 
correlation of this particular tumor type with water 
intake, and significant (P<.05) positive correlation as 
well with partial hepatectomy. There was no significant 
positive or negative correlation as a function of variable 
for the renal mesenchymal tumors.
TABLE IX Liver/Body weight(%) @
4weeks 12weeks 24weeks 36weeks
CARC 4.91 3.80 3.39 3.76
CARC-PH 4.88 * 3.46 3.18 3.55
CARC-AAN 4.30 3.63 3.44 3.65
CARC-PB > 4.97 3.32 3.45 3.54
CARC-eth < 3.80 2.83 3.25 3.22
CONT 4.75 3.48 3.38 3.72
CONT-PH 4.22 3.12 3.12 3,44
CONT-AAN 4.69 3.39 3.71 3.78
CONT-PB > 5.40 4.70 4.26 4,38
COMT-eth < 3. 77 3.16 3.34 3.32
liver/body weights recorded as average s in this table
> significantly higher mean liver/body w t ., except com-
pared to CARC and CONT groups (Duncan s)
< significantly lower mean liver/body wt. as compared to
all other groups (Duncan s)
there was a significant decrease in mean liver/body w t.
between the 4 week and 12 week interval; and a signifi-
cant increase between the 24 week and 36 week interval
TABLE X Statistical Evaluation: Liver wt./Body w t .(%)
Source DF Mean Square Pr >F
Treatment 4 1.22890699 0.0001**
carcinogen 1 0.63294010 0.0161*
treat*carc 4 1.16434310 0.0001**
time 3 11.73847619 0.0001**
treat*time 12 0.23512922 0.0156*
carc*time 3 0.07250955 0.5621
treat*carc*time 12 0.11195074 0.4013
Error 100 0.10555000
** highly significant (P<.01) 
* significant (P<.05)
DF degrees of freedom
TABLE XI Mean Weekly Water Intake (ml/rat) #
mean S.D. var
CARC 79.96 20.69 428.11
CARC-PH 82.82 22.84 521.83
CARC-AAN 63.95 9.93 98.68
CARC-PB 58.56 7.43 53.26
CARC-e th 60.45 13.44 180.61
CONT 109.54 33.52 1123.63
CONT-PH 105.89 30. 36 921.56
CONT-AAN 98.22 26.17 684.75
CONT-PB 85.79 9.00 81.09
CONT-eth 86.20 8.57 73.41
# significantly higher mean water intake observed in
noncarcinogen vs, carcinogen-treated groups
mean water intake was significantly increased by the 
36 week interval as compared to earlier time intervals 
(Duncan's)
TABLE XII Statistical Evaluation: Water Consumption
Source DF Mean Square Pr>F
Treatment 4 1741.417406 0.0004**
carcinogen 1 18011.936344 0.0001**
treat*carcin 4 152.928154 0.7395
time 3 2520.642357 0.0001**
treat*time 12 716.660331 0.0117*
carcin*time 3 654.951351 0.1025
treat*carc*time 12 243.996763 0.6601
Error 100 309.038817
** highly significant (P<.01) 
* significant (P<.05)
DF degrees of freedom
Fig. 56: TEM, alveolar cell hyperplasia, lung. 7000X 
Bar=lum
Fig. 57: TEM, type II pneumocyte, alveolar cell hyper­
plasia, lung. 16,667X Bar=.5um
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Fig. 58: TEM, alveolar/bronchiolar carcinoma. Vacuoles 
with lamellated osmiophilic material (vac). 
8935X Bar=lum
Fig. 59: TEM, A/B carcinoma, lung. 10,333 Bar=lum
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Fig. 60: TEM, A1veolar/bronchiolar carcinoma, lung. Neo­
plastic cells are organized around a central lu- 
mina (L). 5850X Bar=lum
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DISCUSSION
Dimethylnitrosamine, administered as aminopyrine and 
nitrite, proved to be a potent hepatic, renal, and pul­
monary carcinogen in male F344 rats. The nature of the he­
patic, renal and pulmonary lesions was similar to those 
observed in previous studies with DMN (10-20,41-43,47,48- 
52).
For the epithelial cell lines in the particular tar­
get organs, a variety of stages from hyperplastia to ma­
lignant neoplasia could be found to coexist. It is 
tempting to piece together a sequence of morphological 
alterations leading to the end-stage of malignant 
neoplasia from these observations. However, the nature of 
this experiment does not allow this, and one can only make 
educated guesses based on other known work and what is 
currently understood about chemical carcinogenesis. In 
contrast to the epithelial cells, preneoplastic 
alterations were not observed for mesenchymal cell 
elements, as these appeared to arise de novo.
The number of tumors and tumor types varied with ex­
perimental manipulation of the mixed-function-oxidase sys­
tem (Tables I-VIII). Consideration of the possible meta­
bolic effects of these manipulations will be discussed in 
Chapter III.
In treated rats, partial hepatectomy not only in­
creased the number of tumors derived from hepatocytes,
(not statistically significant as compared to CARC and 
CARC-AAN groups) but also resulted in the largest number 
of hemangioendothelial sarcomas of all the treatment 
groups. Evidently two processes are in effect: the 
increased exposure of hepatic DNA to the carcinogenic 
metabolites, due to increased DNA synthesis which is the 
result of the partial hepatectomy; and the effective 
shunting of DMN to other organs capable of its metabolism, 
as removing a large portion of the liver much reduces the 
effective microsomal mass usually responsible for DMN 
metabolism (58,59,60,61).
Aminoacetonitrile (AAN) in this experimental design 
did not appear to be the potent DMN-demethylase inhibitor 
as reported in previous experiments (86,87,88,89,90). In 
fact, during the first 24 weeks of the experiment, livers 
from treated AAN rats were usually more severely affected 
than those of the CARC and CARC-PH groups. This situation 
was somewhat alleviated at 36 weeks, when only half the 
group was found to have neoplastic liver nodules compared 
with the 100% incidence in the CARC and CARC-PH groups.
The number of renal and pulmonary tumors in the treated 
AAN rats suggests an altered intrahepatic metabolism. 
Considering the dose schedule of the AAN injections, 
inhibition of DMN metabolism in any target organ would 
p r o b a b l y  not be of a c o n t i n u o u s  nature. In the l i v e r  it 
may have been enough to allow fairly substantial
q u a n t i t i e s  of DMN to reach the lungs and kidneys; and in 
the lungs and kidneys, the levels of AAN might not have 
been constantly high enough to prevent tumor formation. At 
any rate, the types of DMN-demethylase present in the lung 
and kidney and whether these particular isozymes are 
inhibitable by AAN are unknown at this time (if kidney 
demethylase isozymes aren't inhibited by AAN, it may be 
one explanation why so many RMT's were observed in this 
group). It seems that in the liver the protection provided 
by AAN was partial at best, but may h a v e  been s u f ficient 
to prevent hemangioendothelial sarcomas.
There is some indication that AAN by itself is cap­
able of causing some hepatic damage. Recall that at four 
weeks both control AAN rats had focal areas of hepatic ne­
crosis, and that a few rats sacrificed later on in this 
group had mild to moderate biliary proliferative changes.
In CARC-PB and CARC-eth rats there was significant 
protection of the liver from carcinogenic damage. Livers 
in rats from both these groups appeared nonremarkable on 
gross examination, and had relatively minimal histologic 
alterations. This protective effect did not extend to the 
other DMN target organs, however. If ethanol and 
phenobarbita1 are hepatoprotective due to inhibition of 
DMN-demethylase(s), then their failure to protect other 
organs is somewhat understandable, as both these compounds 
were given orally and were primarily metabolized in the
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liver, and therefore probably did not reach inhibitory 
levels in these extrahepatic tissues. The inhibition in 
the liver was obviously enough to protect the liver and to 
shunt the majority of DMN metabolism to the kidneys and 
lungs.
CARCC-PB rats had both kidney and lung tumors, 
whereas CARC-eth rats had only lung tumors. This CARC-eth 
group is difficult to comparatively evaluate due to the' 
small number of rats in it. The data for this group 
indicates a definite protective effect of ethanol alone 
on the liver, but may a l s o  suggest a shift in the target 
organ specifically to the lung. Tt was in the CARC-eth 
group that the first malignant pulmonary neoplasm arose, 
discovered at the 24 week interval.
The number of DMN-induced pulmonary alterations in 
all the treated rats is particularly striking. Early 
studies with DMN did not suggest the compound could be 
so potent a pulmonary carcinogen (30). Differences in 
dose, rat strain, environment, and a host of other factors 
may be involved, but DMN-induced pulmonary alterations 
bear further investigation. THe effects of concurrent pul­
monary inflammation (mycoplasmosis) with DMN 
administration also cannot be completely discounted in 
this study.
One CONT-PH rat had a fairly significant he­
patic lesion r e s e m b l i n g  those seen ea r l y  in some of the
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treated rats. The was an area of altered hepatocytes. Al­
though F344 rats have a low number of naturally-occuring 
hepatocellular tumors, 20-90" Of control F344 rats at two 
years of age have foci of cellular alteration in the li­
ver (91,92,93). The causes of these foci are not known, 
but dietary carcinogens (i.e. nitrosamines) and promoters 
have been suggested, or it may be genetic predisposition 
(92). The fact that the particular rat being discussed had 
undergone a partial hepatectomy, may implicate the 
hepatectomy as the promoter or 'fixator' of some 
macromo1 ecu 1 ar damage induced by an environmental or feed 
component. At any rate, it also points out that the F344 
strain may not be an ideal one for evaluating 
hepatocarcinogens, especially if there is further 
indication that there is an inherent susceptibility in 
this strain to develop altered foci.
Most of the ultrastructural findings in DMN-treated 
rats have been described previously (13,84,94,95,96). In 
CONT-PB and CONT-eth rats, the lack of SER proliferation 
in the hepatocytes was perplexing, as these substances are 
potent MFO inducers and their effect on SER has been well- 
described (96,97). It was not until the 36 week kill date 
that promnent SER proliferation was observed in the CONT- 
PB group. In the hepatocytes observed u 1 trastructural1 y , 
DMN alone, or combined with other inducers, was a potent 
stimulator of SER proliferation.
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Previous ultrastructural studies have determined that 
there is no single feature which is a marker for hepatic 
neoplasia (94). The present study also indicates that 
hepatic changes occuring early in carcinogen-treated 
groups (i.e. SER proliferation, RER disorganization, nu­
clear alterations, and variations in mitochondrial mor­
phology) were not predictive of the eventual development 
of neoplasia, as the C ARC-PB and C AR C - e t h  rats ea r l y  on in 
the study showed ultrastructural morphological alterations 
similar to other treated groups, but did not progress to 
the same level of neoplastic development.
CARC-AAN rats had no amelioration of DMN-induced 
ultrastructural alterations as compared with other 
carcinogen-treated groups. This is in contrast to a 
previous report which stated that there was a detectable 
decrease in the usual DMN-induced affects on RER, 
mitochondria, and SER when AAN was administered 
simultaneously with DMN (90).
Ultrastructural characteristics described for HES 
coincide with previous reports (16,22,84). Weibel and 
Palade bodies (microtubulated bodies), which are a spe­
cific organelle of vascular endothelial cells (98), 
could not be definitively recognized in any of the neo­
plastic cells. The absence of this particular structure 
is not unexpected in anaplastic tumor types, as were 
seen in treated rats (98) and its presence in rat tumors
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has not been specifically mentioned in previous 
ultrastructural descriptions (84). Of specific interest to 
this study was the prominent bundles of intracytop 1asmic 
filaments in some tumor cells previously identified as 
vimentin filaments (22) which was confirmed by 
immunoh i stoc hemi s t r y .
Neoplastic cells in tumors diagnosed histologically 
as renal adenocarcinomas had ultrastructural characteris­
tics compatible with basophilic tubular cells such as 
abundant free ribosomes, few mitochondria, and a well-de­
v e l o p e d  brush border (37).The p r esence of a p r ominent 
brush border in tumor cells confirms their origin from 
proximal tubular epithelial cells (46,47).
The origin of the RMT is more obscure. In this study, 
the nature of the neoplastic cells generally resembled 
those described as a primitive mesenchymal cell or rest­
ing cortical fibrocyte by Hard and Butler (42,43) and the 
ability of these cells to form blood-filled spaces tended 
to reconfirm their assumption that RMT cells are vasofor­
mative in nature. Hard and Butler (43) were also able to 
examine various areas of the RMT and to describe the ul­
trastructural characteristics associated with the various 
patterns of cell arrangement observed at the light micro­
scopic level. In the present study, the slight variations 
in ultrastructural morphology noted between individual 
neoplastic cells is compatible with the theory that these
tumors arise from a mesenchymal cell capable of differ­
entiating along multiple mesenchymal cell lines (43). 
Specifically, spindle cells containing focal cytoplasmic 
densities of microfilaments closely resemble, in morpho­
logical detail, those cells described as a transitional 
cell type between a pericyte and a smooth muscle cell 
(98).
Carcinomas arising from the bronchoalveolar region 
in the lung proved ultrastructurally to be derived from 
alveolar type II epithelial cells. The crowning diagnos­
tic criterion, of course, was the presence of osmiophilic 
lamellated bodies, specific for this cell type. This is 
in agreement with ultrastructural studies done on other 
nitrosamine-induced pulmonary neoplasms in F344 rats, al­
though DMN was not one of the nitrosamines used (51). No 
other cell types were observed to suggest an alternative 
cell of origin, as reported in Syrian golden and European 
hamsters (52).
CHAPTER III
Examination of the Effects of Various Manipulations of 
the Mixed-Function-Oxidase System in Male F344 Rats on 
Hepatic O-Demethylase Activity as Measured by the P- 
Nitroanisole Assay 
ABSTRACT
Male F344 rats given the DMN precursors aminopyrine 
and nitrite in the drinking water were subjected to vari­
ous manipulations of the mixed-function-oxidase system in­
cluding: partial hepatectomy, subcutaneous injections of
a m i n o a c e t o n i t r i l e ,  p h e n o b a r b i t a l  (1.75%ethanol) 
administered in the drinking water, and 1.75% ethanol 
also administered in the drinking water. Control groups of 
rats u n derwent the same m a n i p u l a t i o n s ,  but c a r c i n o g e n i c  
pre c u r s o r s  were not i n c l u d e d  in the dri n k i n g  water. 
Specific activities of O-demethylase as measured by a p- 
nitroanisole assay were used as indicators of induction or 
suppression of the mixed-function-oxidase system in 
treated and control rats. Specific patterns of such 
induction and suppression could be gleaned from the data 
obtained, the most consistent and striking of which was 
the induction of the O-demethylase enzyme seen in treated 




The drug metabolizing enzyme system is localized pri 
marily within the liver and consists of a NADPH-specific 
flavoprotein (NADPH-cytochrome C reductase), a phospholi­
pid component, and a terminal cytochrome (P-450 or P-448) 
(101). In general, the products of metabolism by this 
system are less toxic than the parent compound; however, 
there are many xenobiotic compounds, such as dimethylni- 
trosamine (DMN), which are converted to compounds of in­
creased toxicity upon metabolism by this system (101).
DMN is oxidatively demethylated by the drug metabo­
lizing enzyme system in the target organs (primarily the 
liver) to monomethylnitrosamine which subsequently under­
goes nonenzymatic decomposition to the ultimate carcino­
gen, the carbonium ion (54). DMN-demethylase is the mixed 
function-oxidase enzyme responsible for the initial deal- 
kylation of DMN (54). DMN-demethylase, in the liver at 
least, exists in several isoenzymic forms which have a 
different affinity for the nitrosamine substrate (71,75). 
Due to'these multiple isoenzymes, DMN-demethylase has an 
atypical reaction to the "classic" MFO inducers, which 
is primarily dependent on substrate concentration (54, 
73). Phenobarbital, for example, has been found to be 
an inducer of DMN-demethylase only at relatively high 
concentrations of DMN (65,75).
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Other manipulations of the MFO system have been at­
tempted. Partial h e p a t e c t o m y  e f f e c t i v e 1 y ,a 1 1hough 
temporarily removes a large block of the drug metabolizing 
enzyme s-ystem in the liver, hindering the exclusive first- 
pass metabolism of DMN,which allows increased amounts of 
DMN to reach the general circulation,thus exposing other 
target organ systems (58,59).
Aminoacetonitrile (AAN) is a lathrogenic compound 
known to be an inhibitor of DMN-demethylase as it lowers 
the methylation rate of hepatic RNA and delays hepatic 
carcinogenesis (66,86,87,89), Ultrastructural findings 
suggest that when AAN is administered simultaneously with 
either d i m e t h y 1 n i t r o s a m i n e  or d i e t h y 1 n i t r o s a m i n e , it 
a p p e a r s  to h a v e  a d i r e c t  s t a b i l i z i n g  e f f e c t  on the 
c y t o p l a s m i c  m e mbrane systems and r i bosomes in the ea r l y  
stages of nonspecific liver damage by these compounds 
(90).
The effects of ethanol on the microsomal metabolism 
of xenobiotics depend on the particular xenobiotic. In 
rats given ethanol there is a proliferation of SER, as­
sociated with an increase in phospholipids, cytochrome P- 
450 reductase, and a distinct form of cytochrome P-450 
(97). Its effects on DMN metabolism by the microsomal 
enzyme system seem to depend on whether ethanol is ad­




140 male F344 rats at six weeks of age were randomly 
assigned to five c a r c i n o g e n - t r e a t e d  groups and five 
n o n c a r c i n o g e n  c o n t r o l  g r o u p s .  T r e a t m e n t  g r o u p s  a l l  
received aminopyrine (lmg/ml) and nitrite (lmg/ml) in 
their drinking water (tap water). Twenty-four rats 
received only these precarcinogenic compounds (CARC). In 
addition, twenty-four carcinogen-treated rats underwent 
partial hepatectomy to effectively remove one-third of the 
liver mass (CARC-PH). 24 treated rats received 
subcutaneous injections of AAN (20 mg in 0.2 ml normal 
saline) three times weekly (CARC-AAN). Twenty-four rats 
received 0,5 mg of phenobarbital per ml drinking water 
(CARC-PB). Since the particular water-soluble formulation 
of phenobarbital contained ethanol an additional 4 treated 
rats received ethanol in their drinking water at a 
concentration of 1.75% (CARC-eth). Control rats did not 
receive aminopyrine and nitrite in their drinking water 
and included: 8 rats receiving unadulterated tap water 
(CONT), 8 rats which had undergone one-third partial 
hepatectomy (CONT-PH), 8 rats which received three weekly 
injections of AAN (20 mg in .2ml normal saline) (C0NT- 
AAN), 8 rats which received 0.5 mg phenobarbital (and 
1.75% ethanol) per ml of tap water (CONT-PB), and 8 rats 
reciving ethanol at a concentration of 1.75% (CONT-eth).
All rats were kept on their respective treatment and
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control regimens for five days per week. On weekends, all 
rats received fresh tap water as their water supply.
One-fourth of the rat population of each of the 
carcinogen-treated and control groups was killed at 
the following time intervals subsequent to the start of 
the experiment: 4 weeks, 12 weeks, 24 weeks, and 36 weeks.
At necropsy, enough liver was saved from each rat to 
make up a total weight of 10-12 grams of fresh liver per 
treatment or control group. The liver samples from each 
of the control or treatment rats were pooled together 
per group and stored at -70°C in glass vials until mi­
crosomal analyses could be performed.
At the time of microsomal analysis, frozen liver sam­
ples were thawed and placed in a beaker of cold 1.15% KC1 
and swirled to remove as much blood as possible. The liver 
samples were then coarsely minced with scissors and placed 
in two volumes of cold 1.15% KC1. This KC1 was discarded 
and the liver samples homogenized in two volumes of 1.15% 
KC1 using a glass homogenizing vessel with a teflon pes­
tle for ten strokes using a loose-fitting pestle, follow­
ed by two to four strokes with a tight-fitting pestle.
This homogenate was centrifuged at 3000xg (7000 rpm) for 
15 minutes at 4-5°C using a Dupont Sorvall RC-5B Refriger­
ated Superspeed Centrifuge. The supernatant was then cen­
trifuged further at 9000xg (11,000 rpm) for 20 minutes. The 
supernatant from this second centrifugation was filtered
through cheesecloth, and the pellet was discarded.
Three screwtop glass conical 15 ml centrifuge tubes 
were prepared as follows: the reaction tube contained 5.0 
ml 0.2M PO^ buffer, pH 7.4 (Sigma Chemical Company), 20ul 
0.5M D-Glucose-6-phosphate, sodium salt (Sigma Chemical 
Company), 50 ul 0.1M NADP, sodium salt (Sigma Chemical 
Company), 100 ul 5mM M g C ^  (Sigma Chemical Company), 2.03 
ml distilled water, and 1.8 ml of the enzyme preparation 
(supernatant). The standard tube contained 5,0 ml 0.2M PO^ 
buffer, 2.20 ml distilled water, and 1.8 ml enzyme 
preparation. The blank tube contained 5.0 ml 
0.2M PO^ buffer, 3.2 ml distilled water, and 1.8 ml enzyme 
preparation. The well-mixed contents of each of these tubes 
were divided into two equal aliquots which constituted the 
replicates.
A mixture of 95% oxygen and 5% carbon dioxide was 
then bubbled gently through the contents of each tube 
using pasteur pipettes. All tubes were then capped. The 
reaction and standard tubes were placed in a 37°C water 
bath with a shaker mechanism to equilibrate, while the 
blank tubes were placed on ice.
The 0-demethylase reaction was initiated in the reac­
tion tubes by the addition of 0.5 ml of 3mM p-nitroanisole 
substrate (Aldrich Chemical Company). 0.5 ml of 2mM p- 
nitrophenol standard (Sigma Chemical Company) was added to 
the standard tubes. These tubes were then recapped and
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incubated in the 37°C water bath for 30 minutes. The blank 
tubes were kept on ice.
At the end of the 30 minute incubation, 5 ml of 10% 
trichloroacetic acid (Sigma Chemical Company) was added to 
each tube to stop the reaction. These tubes were then 
centrifuged on a Beckman Model TJ-6 centrifuge at 2500 rpm 
for 15 minutes to remove the precipitated protein, 3 ml 
of this supernatant was transferred to a second tube con­
taining 2.0 ml 0.5N NaOH (Sigma Chemical Company).
These tubes were then centrifuged on the Sorvall at 
2000xg for 10 minutes. The supernatant was placed into 
glass tubes (Fischerbrand Culture Tubes, Fischer Scienti­
fic Company) and the absorbance was recorded at 400 nm 
against a distilled water blank using either a Bausch and 
Lomb Spectronic 20 spectrophotometer or a Coleman Junior 
IIA Linear Absorbance Spectrophotometer.
The average absorbance at 400 nm of the sample blank 
was subtracted from the average absorbances of the reac­
tion and standard tubes. These corrected absorbances were 
used in the following calculations:
average absorbance of reaction sample = x umoles(rxn) 
average absorbance of standard sample 1.0 umole(std)
where x is the umoles of p-nitrophenol present in the re­
action tube at the end of the 30 minute incubation or, in 
other words, the number of umoles of p-nitroanisole meta­
bolized over the incubation period. Then this value (the 
number of umoles of p-nitroanisole metabolized) was di­
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vided by 30 minutes multiplied by the mg protein present 
in the reaction tube, to finally obtain a value termed 
the specific activity, in this case of the 0-demethylase 
enzyme. Milligrams of protein was the protein concentra­
tion in mg/ml multiplied by ,9 ml, which was the mg protein 
present in the reaction tube. This particular protein con­
centration was determined by the Biuret method.
Protein Determination by the Biuret Method:
Two sets of glass tubes (Pyrex No. 9800) were number­
ed from 1 to 10. In the standard set, 0.0, 0.1, 0.2, 0.3, 
0.4, 0.5, 0.6, 0.7, 0.8, and 1.0 ml of a 10 mg/ml solution 
of bovine serum albumin (BSA) (Sigma Chemical Company) was 
added to tubes numbered 1, 2, 3, 4, 5, 6, 7, 8, 9, and 10 
respectively. In the unknown set of tubes, amounts of en­
zyme preparation identical to the amounts of 10% BSA added 
in the standard tubes were added. The total volume of each 
tube (standard and unknown) was brought to 1.0 ml by the 
addition of a corresponding amount of distilled water.
4.0 ml Biuret reagent was then added to each tube, and the 
tube contents were mixed thoroughly. Test tubes were then 
incubated in a 37°C water bath for 20 minutes. Absorbances 
were then read at 540 nm on a spectrophotometer.
Absorbances from the standard tubes were plotted ver­
sus milligrams of protein. The resulting standard plot was 
used to determine the milligrams of protein per milliliter 
of enzyme preparation. This figure was subsequently used
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in the formula presented above, to determine specific ac­
tivity.
T h e  s t a t i s t i c a l  m o d e l  for t h i s  s e c t i o n  was a 
c o m p l e t e l y  r a n domized design with a f a c t o r i a l  treatment 
arrangement. Duncan's Multiple Range test was also 
performed using the multiple variables.
RESULTS
Specific activities for the hepatic O-demethylase 
enzyme are presented in Table XIII. Treatment effects were 
significant (P<.05) with both CARC-PB and CONT-PB groups 
having the most significantly elevated enzyme activity. 
CARC-eth and CONT-eth groups also had significantly 
elevated O-demethylase activity, although not to the 
extent of the phenobarbita1 groups. CARC, CONT, CARC-PH, 
CONT-PH, CARC-AAN, and CONT-AAN groups had specific 
activities that were not significantly different from each 
other ( P > . 0 5 ).
The presence or absence of carcinogens had no 
significant effects (P>.05) on the 0-demethy 1 ase 
activities. Activities measured at the 4 week, 12 week, 
and 36 week interval were not significantly different from 
each other (P>,05). However, the enzyme activities 
measured at the 24 week interval were significantly lower 
(P<.05) when compared to the other time intervals (Tables 
XIII and XIV).
TABLE XIII Specific Activities, O-demethylase @
P-nitroanisole Assay
4weeks 12weeks 24weeks 36weeks
CARC 2.02 1 .16 1 .30 1 .38
CARC-PH 2.49 2.49 1.25 1.86
CARC-AAN 1.72 2.02 0.86 1.08
CARC-PB >> 2.98 3.09 2.86 4.01
CARC-eth > 2.02 1.71 1.60 2.69
CONT 1.68 1 .93 1 .55 2.19
CONT-PH 1 . 53 1.91 1 .27 0.79
CONT-AAN 1.35 1.91 0.63 1 .85
CONT-PB >> 3.94 2.91 2.40 4.08
CONT-eth > 3.07 2.90 0.55 3.25
specific activities expressed as 1x10” umoles p- 
nitroanisole metabolized/ 30 min. x mg. protein 
@ no significant differences in enzyme activities between
carcinogen and noncarcinogen groups (Duncan's)
>> highest enzyme activity (significant) (Duncan's)
> significantly higher enzyme activity than other groups
but significantly lower than PB groups (Duncan's)
TABLE XIV Statistical Evaluation: O-demethylase Enzyme
Activity
Source DF Mean Square Pr>F
treatment 4 4.46826875 0.0001**
carcinogen 1 0.01722250 0.7953
treat*carc 4 0.34801625 0.2855
week 3 1.83568917 0.0043*
treat*week 12 0.35571208 0.2634
carc*week 3 0.13497583 0.6567
Error 12 0.24468625
** highly significant (P<.01) 
* significant (P<.05)
DF degrees of freedom
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DISCUSSION
The measurement of O-demethylase activity was used 
in this study merely as an indicator of stimulation or 
suppression of the mixed-function-oxidase system, speci­
fically whether there were alterations in the activity of 
the P-450 responsible for the O-demethylase reaction. It 
is in no way i n d i c a t i v e  of nor can it n e c e s s a r i l y  be 
extrapolated to the activity of the DMN-demethylase system 
in the variously manipulated experimental and control 
groups. Specifics on the activity of DMN-dernethy1 ase in 
rats on this experimental design are merely speculative, 
and based on the often contradictory evidence present in 
the literature.
O-demethylase activity was highest in both treated 
and untreated rats receiving phenobarbital. This is com­
patible with many enzyme systems with exposure to pheno­
barbital, but it is in direct opposition to the effects 
of phenobarbital on DMN-demethylase as put forth in most 
of the literature. There have been a few reports that, 
like the increase in hepatic O-demethylase activity 
with phenobarbital, hepatic dealkylation of DMN is in­
creased in rats receiving phenobarbital (68). However, 
most other studies reported an inhibition of DMN-demethy- 
lase by phenobarbital; the discrepancies between these 
findings were believed to be due to the various doses of 
DMN used and to multiple enzymic forms of DMN-demethylase,
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Arcos et al (65) reported that DMN-demethy 1 ase 
existed in two enzymic forms, DMN-demethylase I and II, 
which had different kinetic characteristics and which 
responded differently to enzyme inducers. DMN-demethylase 
I was a c t i v e  at a DMN c o n c e n t r a t i o n  range of 0 - A m M  and was 
inhibited by inducers such as phenobarbital, whereas DMN- 
demethylase II was active at higher substrate 
concentrations, in a range of 50-200mM of DMN, and was 
induced by phenobarbital (65).
Slightly different versions of the same phenomenon 
have been formulated. Tu and Yang (73) suggested that the 
multiple Km values of DMN-demethylase were due to the pre­
sence of P-450 isoenzymes in the microsomes. In fact, at 
least six forms of cytochrome P-450 with DMN-dernethylase 
activity have been isolated (107). The major forms of 
P-450 induced in the rat liver by phenobarbital probably 
have low affinities for DMN. Thus, when assayed at a 
substrate concentration of l-4mM, DMN-demethylase activi­
ty is depressed by phenobarbital due to competition be­
tween the induced isoenzymes and the existing higher af­
finity isoenzymes for NADPH-P-450 reductase (73).
Other mechanisms of how phenobarbital inhibits DMN 
carcinogenesis aren't necessarily related to the multiple 
forms of DMN-demethylase. Phenobarbital has been observed 
to have an inhibitory effect on hepatocarcinogenesis when 
fed simultaneously with a number of hepatocarcinogens,
which may be the result of a phenobarbital-mediated shift 
in the carcinogen's metabolism toward that of detoxifica­
tion and degradation (108). For example, phenobarbital gi 
ven simultaneously with 2-acetylaminofluorene increased 
the level of the carcinogenic intermediate, but enhanced 
the level of excretion of the conjugated glucosiduronic 
acid derivatives (109). A suggestion that phenobarbital 
preferentially induces an alternate microsomal pathway of 
DMN metabolism has been put forth (74,110). This has been 
discounted as not an important in vivo mechanism, however 
and suggests that phenobarbital has an effect on the cel­
lular level rather than on carcinogen metabolism (111).
Alternatively, since many inducers of microsomal en­
zymes are also substrates for these enzymes, there may be 
competition for enzyme-binding sites between the inducer 
and the carcinogen, resulting in less metabolism of the 
carcinogen in the particular target organ (97).
There is the additional possibility that microsomal
inducers in the liver stimulate the enzyme(s) responsi-
£
ble for the removal of 0 —methylguanine alkylation 
product from DNA, and that this may be their mechanism of 
protecting the liver. This particular enzyme system is 
believed to be inducible by chronic DMN administration 
in the liver (55,64), but not to be so in the kidney and 
lung, which may be the result of the low amount of DMN 
which usually reaches these organs in comparison with the
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liver (64).
Administration of ethanol in treated and control rats 
also generally stimulated O-demethylase activity, although 
not to the same level as did phenobarbital. Since the phe­
nobarbital formulation used contained ethanol, the higher 
level of induction of O-demethylase in rats receiving phe­
nobarbital may be due to additive inductive effects of 
both phenobarbital and ethanol. The effects of ethanol on 
the DMN-demethylase enzyme system were evidently not si­
milar to those on O-demethylase, as ethanol had a sparing 
effect on the liver.
The reported effects on DMN metabolism have been con­
tradictory. Several researchers have reported an enhanced 
metabolism of DMN by both acute and chronic ethanol admi­
nistration (106,107,112). In these situations ethanol ad­
ministration was followed by sacrifice of the animal, har­
vesting of the microsomes, and in vitro measurements of 
DMN metabolism by the ethano1-induced microsomes 
(106,107). The effects of ethanol on DMN metabolism in 
these manipulations is markedly increased by a low 
carbohydrate intake, as it appears that dietrary 
carbohydrates play an important role in regulating the 
activity of liver drug-metabolizing enzymes for certain 
xenobiotics (105).
Administration of ethanol following the conclusion 
of a carcinogenic regime has been found, in one study,
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to increase the number of preneoplastic foci in the li­
ver (102). Alternatively, a study by Schwarz et al (103) 
found that ethanol, when administered with diethylni- 
trosamine, increased the number and size of altered hepa­
tic foci, but had no effect on altered foci when given 
after the carcinogen treatments had stopped. The study 
by Schwarz indicates that ethanol, unlike phenobarbital, 
does not have promoter activities (103).
However, none of this work explains what was seen in 
this study. Chronic ethanol consumption simultaneous with 
diethylnitrosamine administration has been found to de­
crease the incidence of hepatic tumors (113). In this 
dissertation project, simultaneous administration of DMN 
with 1.75% ethanol resulted in livers that were macrosco- 
pically nonremarkable as compared with controls and only 
contained mild, early hepatocarcinogenic processes 
histologically.
The lungs of treated rats receiving ethanol were not 
spared, however, as rats in this group developed areas of 
alveolar cell hyperplasia, bronchiolar-alveolar adenomas 
and carcinomas. It has been noted that the concurrent ad- 
minstration of DMN and ethanol to C57BL mice resulted in 
a shift in the target organ from the liver to the ethmoid 
turbinate region (104).
Aminoacetonitrile (AAN) appears to have slightly in­
hibited (although, not significantly) the activity of the
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O-demethylase enzyme in both treated and control groups.
In the treated rats receiving AAN this inhibition was more 
evident during the latter half of the experiment, while in 
the control group inhibition was fairly constant 
throughout. AAN has been proposed as a potent inhibitor of 
DMN-demethylase in the rat liver (86,87,88,89,90,114). AAN 
has also been shown to protect the liver against damage 
from other compounds such as carbon tetrachloride, 
allylamine, bromobenzene, chloroform (89), 
diethylnitrosamine (87), and thioacetamide (88). Since 
it affects a variety of enzyme systems, it is probably not 
surprising that AAN would have a similar effect on the 0- 
demethylase enzyme.
Despite the fact that in the literature AAN lowers 
the metabolic rate of removal of methyl groups from DMN 
and decreases the methylation rate of liver nucleic acids, 
AAN has not been found to c o m p l e t e l y  p r e v e n t  tumor d e ­
velopment when given simultaneously with DMN (86). In the 
present study, the specific effects of the AAN 
administered on DMN-demethylase are unknown, but gross, 
microscopic, and ultrastructural findings in treated rats 
reveal that AAN was not successful in completely 
preventing hepatocellular and biliary preneoplastic and 
neoplastic alterations. There was evidence that AAN did 
alter hepatic DMN metabolism, as there were of number of 
extrahepatic tumors induced in both the kidneys and lungs,
142
which suggests that an increased amount of DMN was 
reaching these target organs.
AAN is a structural analog of the haloacetonitriles 
which are direct-acting alkylating agents (114), There­
fore there is the possibility that AAN alone may have 
some independent toxic effects. Control rats receiving 
AAN did have focal areas of hepatic necrosis after 4 
.weeks on AAN. This may have nothing to do with AAN, as 
such areas were not seen in rats sacrificed from the same 
control group later on, although several of these animals 
had slight proliferation of bile ducts and mild to moder­
ate associated portal fibrosis.
A more significant inhibitory effect of AAN on DMN- 
demethylase and perhaps O-demethylase might have been ob­
served at a higher dose than 20mg thrice weekly or at the 
same dose, but administered daily, as the influence of AAN 
on DMN metabolism has been reported not to exceed 20 hours 
(86).
AP + nitrite seemed to have a generally inhibitory 
effect on O-demethylase activity (not significant). This 
may be due to the toxic effects of DMN on hepatic SER,
RER, and mitochondria (90), resulting in loss of some 
specific enzyme activities, and perhaps stimulating 
others. U1trastructura 1 ly, AP + nitrite generally induced 
hepatic SER, which brings up the point that such induced 
systems do not actually exhibit an increased activity of
all of their associated enzyme sytems.
Partial hepatectomy did not have a constant effect 
on O-demethylase activity (no significant increase or 
decrease in enzyme activity throughout the experiment). 
Treated PH rats did have a slight induction of such 
activity at 4 weeks, but not afterwards. Control PH rats 
had a general inhibition of O-demethylase which was noted 
throughout the experiment. The effect of PH on DMN- 
demethylase activity in treated rats was probably of a 
temporary nature in itself, but was enough to allow 
sufficient unmetabolized amounts of DMN to reach the 
kidneys and lungs where tumors could be induced.
CHAPTER IV
Characterization of Dimethy1 nitrosamine-Induced Hepatic, 
Renal, and Pulmonary Neoplasms in F344 Male Rats Utilizing 
Immunocytochemical Techniques 
ABSTRACT
Selected hepatic, renal and pulmonary neoplasms 
induced in male F344 rats on a regimen of aminopyrine and 
nitrite administered in the drinking water, and with 
various manipulations of the mixed-function-oxidase sys­
tem, were evaluated using the avidin-biotin immunoperoxi­
dase technique.
This immunocytochemical technique proved useful in 
characterizing the cell of origin of some of these tumors, 
especially when combined with the gross, histologic, and 
ultrastructural findings. Tumors ammenable to this stain­
ing technique included hepatic hemangioendothelial sarco­
mas and their pulmonary metastases, renal mesenchymal tu­
mors, and preneoplastic changes or benign neoplasms 
derived from bile duct epithelium. Cytokeratin primary 
antibodies were of limited value in labeling 
preneoplastic, benign or malignant neoplasms derived from 
renal proximal tubular epithelial cells, hepatocytes, and
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pulmonary epithelium. It was concluded that this staining 
technique provided a useful adjunct in characterizing DMN- 
induced tumors.
INTRODUCTION
In the last seven years immunocytochemistry has be­
come an important tool in determining the cell of origin, 
and therefore aiding in the diagnosis, of various neo­
plasms. In tumor diagnosis, most immunocytochemical tech­
niques have been used to label intermediate-sized, or 
10 nm, filaments, which are a major cytoskeletal component 
in vertebrate cells and which appear to be retained during 
n e o p l a s t i c  t r a n s f o r m a t i o n  and within solid m e t a s t a s e s  
(79,81). These intermediate filaments (IFs) lie within the 
classification of five major subtypes: 1) Cytokeratins —
characteristic of epithelial cells 2) vimentin - typical 
of m e s e n c h y m a l  c e l l s  and found with other IF types in 
certain nonepithelial tissues and in cultured epithelial 
cells 3) Glial Fibrillary Acidic Protein - which occurs in 
a s t r o c y t e  d e r i v a t i v e s  4) desmin - which is a marker of
most my o g e n i c  d i f f e r e n t i a t i o n s ,  and 5) n e u r o f i l a m e n t s  -
1
found in most neurons (77,79,83).
Of the five families of IFs, the cytokeratins have 
proved, so far, to be the most diverse, the result of ex­
pression of a complex multigene family with highly related 
yet distinct structural domains (83). Nineteen human 
cytokeratin subtypes have been classified and cataloged
on the basis of their positions on two-dimensional gel 
electrophoresis (83). The apparent molecular weights of 
the cytokeratins range from 40,000 to 68,000 daltons (81). 
The distributions of these various cytokeratin proteins 
varies with the type of epithelia, a given epithelium can 
therefore be characterized by the specific pattern of its 
cytokeratin proteins (81,83). For example, the 
nonstrat'ified epithelia of the digestive tract and its 
associated glands and ducts tend to express a relatively 
simple cytokeratin composition, containing only 2 to 4 
major polypeptides, two of which are the earliest 
cytokeratins expressed during embryogenesis (81). The 
epidermis and other stratified epithelia, on the other 
hand, tend to express a large number of other acidic and 
basic cytokeratins, and lack the cytokeratins present in 
simple epithelial cells (81).
The IF types of desmin, vimentin, and GFAP all con­
sist usually of only one type of subunit protein (81). 
Neuronal filaments, which consist of a triplet protein, 
may exhibit a different distribution of each triplet 
component in various nervous tissues (79).
Characterization of intermediate filaments of rat 
nitrosamine-induced, epithelial and mesenchymal hepatic 
neoplasms has been attempted using both immunofluore­
scence and electron microscopy (22). An excess of micro- 
and intermediate-sized filaments was noted in many neo-
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plastic cells; particularly, vimentin filament accumula­
tion was noted in certain malignant endothelial cells 
(22). Immunofluorescence revealed that hemangioendothe 1 ia 1 
sarcoma cells stained strongly for vimentin, whereas both 
hepatocellular carcinomas and cholangiofibromas stained 
for cytokeratin (22). This particular study indicated 
the potential that immunologically labelling IFs could 
have in regard to diagnosis and classification of carci­
nogen-induced neoplasms (22).
Application of iramunohistochemical techniques to 
forma1 in-fixed,paraffin-embedded tissue has now become 
widespread in labelling not only IFs, but also an array of 
other histologically significant cellular antigens. These 
include Factor VIII complex, which refers to a single 
protein or complex of related proteins important 
in the initiation of coagulation and platelet function.
The purified protein(s) has three functionally distinct 
components: an antigen, a clot-promoting factor, and von 
Willebrand factor (115), Vascular endothelium, megakaryo­
cytes, and platelets all react to rabbit antiserum to 
Factor V IIl-re1ated-antigen (115). Synthesis of Factor 
V U I - r e l a t e d - a n t i g e n  occurs in endothelial cells (116), 
both vascular and lymphatic, although in lymphatic 
endothelia, it is reduced compared to vascular endothelial 
cells (116).
A variation of the immunoperoxidase staining proce­
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dure called the "ABC" technique (for avidin-biotinylated 
horseradish peroxidase complex) is a sensitive, essenti­
ally irreversible technique for labelling cellular anti­
gens (117). Avidin is a 68,000 molecular weight glycopro­
tein which has a high affinity for the low molecular 
weight vitamin, biotin. Avidin has four binding sites for 
biotin and most proteins can be conjugated with several 
molecules of biotin. The first step in the ABC procedure 
is the incubation of the tissue section with the primary 
antiserum prepared against the antigen of interest. Next, 
a biotin-labelled secondary antibody is added, followed by 
the horseradish peroxidase complex which binds to the bi- 
otinylated secondary antibody. The antigen is visualized 
through incubation with a substrate solution, which con­
sists of a solution of chromagen and hydrogen peroxide 
(117). The high affinity of the avidin molecule for the 
biotin molecule is primarily responsible for the increased 
sensitivity of this technique over the peroxidase-anti- 
peroxidase method, an alternative technique which uses 
a reagent consisting of peroxidase molecules combined with 
antiperoxidase antibodies.
MATERIALS AND METHODS
Tissue samples used for immunocytochemical evaluation 
were selected from those retained from carcinogen-treated 
ratsand control rats at the various kill intervals.
At the time of necropsy examination, representative
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tissue samples from the liver and kidney were fixed in 10% 
neutral buffered formalin (NBF) at room temperature 
or at 4°C in 100% acetone or absolute ethyl alcohol for 
approximately 24 hours. Sections were then processed and 
paraffin-embedded. Tissue samples from all body organs 
were placed in 10% NBF until they were routinely processed 
and paraffin-embedded. It was these latter samples that 
provided most of the tissue which was stained and exam­
ined.
Selected paraffin-embedded tissue blocks were 
sectioned at 4-6 urn and sections vere incubated 
overnight (8-12 hours) on glass slides at 50~55°C to 
adhere tissue sections adequately to the slides. Sections 
were then deparaffinized in xylene (three separate 
changes, 3 minutes each) followed by alcohol (three 
separate changes, 2 minutes each). Slides were then washed 
thoroughly in tap water.
Slides were placed in phosphate buffered saline (PBS) 
for 10-12 minutes. Endogenous peroxidase activity was in­
hibited by covering the tissue sections with 3% H 2 O 2 
for five minutes, usually in a 37°C incubator. Slides 
were washed in distilled water and placed in PBS in a 
37°C incubator. Staining procedures were performed in 
petri dishes lined by moistened filter paper. Petri dishes 
were also placed in the incubator with the tissue 
sections, as the trypsinization procedure required that
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the tissue sections be prewarmed to 37°C.
If tissue sections to be stained contained numerous 
R B C ’s, an alternative blocking procedure was used to pre­
vent the violent tissue reaction that can occur when RBC's 
react with hydrogen peroxide. In these cases, a .6% hydro­
gen peroxide in methanol solution was used for one-half 
hour at 37°C. Slides were washed, placed in PBS and 
returned to the incubator.
Tissue sections were covered in a .1% solution of 
porcine trypsin (Trypsin 1:250, Difco) and calcium chlor­
ide, pH adjusted from 7.6 to 7.8, at 37°C for 15 
minutes. Slides were then washed in cold PBS, and placed 
in fresh PBS for 10 minutes (fresh PBS was used after each 
step).
Tissue sections were covered with blocking antibody, 
which was a nonimmune serum from the same species as the 
secondary biotinylated antibody, for 20-60 minutes at room 
temperature (20 minutes was the commonly used incubation 
period). For polyclonal BioGenex products a premixed Bio- 
Genex nonimmune goat serum (BioGenex Laboratories, Dublin, 
CA) was used. For monoclonal BioGenex, DAK0, and Triton 
products, a nonimmune equine serum (VECTOR 
LABORATORIES,Inc. Burlingame, CA) was used, mixed ac­
cording to kit directions.
Basically, two kits were used in these procedures.
A StrAviGen (Biotin-StreptAvidin Amplified System-BioGenex
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Laboratories, Dublin, CA) kit was used primarily in local­
izing Factor VUI-relat e d - a n t i g e n  in various tissue sec­
tions as well as polyclonal cytokeratin. A Vectastain 
ABC kit (VECTOR Laboratories, Burlingame, CA) was used 
in cases where mouse monoclonal antibodies were employed 
as the primary antibodies.
After incubation with the blocking antiserum, excess 
serum and buffer were carefully blotted from around the 
tissue and the primary antibody was applied. Primary anti­
bodies used included polyclonal rabbit anti-human 
cytokeratin, prediluted (BioGenex Laboratories), polyclon­
al rabbit anti-human Factor VIII related antigen, 
prediluted (BioGenex Laboratories), monoclonal mouse anti- 
porcine vimentin, 1:500 dilution (BioGenex Laboratories), 
MAK-6 monoclonal mouse anti-human cytokeratin cocktail,
1:5 dilution (Triton Biosciences, Alameda, CA), and 
mouse monoclonal anti-porcine desmin, 1:50 dilution (DAKO 
Corporation, Santa Barbera, CA). Dilutions of monoclonal 
antibodies were done with .1% bovine serum albumin in PBS. 
Incubation with the primary antibody was carried out for 
18 to 24 hours at 4°C.
A positive and a negative control slide was run with 
each unknown tissue. Negative controls consisted of a 
duplicate tissue section, identical to the unknown, but 
instead of being incubated with the primary antibody, this 
slide was incubated with either a nonimmune mouse
serum (Vector Laboratories) if the primary was a monoclon­
al antibody, or with a rabbit nonimmune serum (Vector 
Laboratories) if the primary was a polyclonal 
antibody. Alternatively, incubation with PBS instead of 
the primary antibody could be used as a negative control.
Selection of tissues to serve as positive controls 
presented more of a problem, as ideally human tissues 
should be utilized, and such tissue sections were not 
readily available. Instead a variety of normal rat tis­
sues from controls, or normal tissue present on the un­
known slide were used as positive controls. The speci­
fic rat tissues to be used as positive controls were 
then set up on a trial and error basis. Those particular 
tissues which stained relatively strongly, specifically, 
and reliably on multiple incubations with a particular 
primary antibody, duplicating the exact procedural steps 
utilized for the unknown tissue, were deemed satisfactory 
to be used as positive controls.
Following the incubation with the primary antibody 
(or with nonimmune serum for the negative controls) slides 
were washed in several changes of PBS for 10-20 minutes. 
Then the tissue sections were incubated with the secon­
dary biotinylated antibody (BioGenex, Vector Laboratories) 
which was prediluted or diluted per kit instructions. This 
incubation took place at room temperature for 30 minutes.
Slides were washed in PBS for 10 minutes and then
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tissue sections were incubated with the ABC reagent (Bio­
Genex, Vector) for 60 minutes at room temperature. This 
reagent also came prediluted (BioGenex) or was diluted per 
kit instructions (Vector). Following this incubation, 
slides were washed in PBS.
Tissue sections were then incubated with the chroma- 
gen substrate solution for 40 minutes at room temperature. 
The substrate solution used was 4 mg of 3-amino-9-ethyl- 
carbazole (Sigma Chemical Company) dissolved in 1ml N,N- 
dimethyl formadide (Sigma Chemical Company). This was 
mixed with 14 ml of 0.1N ac e t a t e  buffer, pH 5.2 and 0.15 
ml 3% hydrogen peroxide. This solution was made up fresh 
immediately prior to use and filtered to remove the preci­
pitate.
After substrate incubation, tissue sections were 
washed in deionized water for 5 minutes, counterstained 
with Mayer’s hematoxylin, and dipped ten times in ammo­
nia water. Sections were then gently rinsed with tap wa­
ter for two minutes and coverslipped with glycerin gel. 





Neoplastic endothelial cells exhibited strong, posi­
tive and specific cytoplasmic staining (Fig. 1 ) with mo-
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Fig. 1: Positive vimentin immunoreactivity (arrowheads). 
Hemangioendothelial sarcoma, liver. 20X
Fig. 2: Positive vimentin immunoreactivity (arrowheads).
HES, lung. 50X
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derate variation in intensity. Filaments could often be 
localized to certain regions within the cytoplasm, as 
they occured in solid clumps or aggregates, or heavily 
populated the more peripheral cytoplasmic zones in the 
l a r g e r , m o r e  a n a p l a s t i c  c e l l  types.In s p i n d l e - s h a p e d  
cells, filaments were often localized to one pole or 
"tail” , and conformed with the spindleloid nature of the 
cell.
Other cells in the liver which labelled with vimen­
tin included scattered spindle cells in the hepatic cap­
sule, several spindle-shaped cells in regions of cholan- 
giofibrosis, and the internal and external elastic lamina 
of hepatic arteries. This positive specific staining 
of the elastic lamina occurred in arteries in all tissue 
types, not exclusively those in the liver.
Biliary epithelia and most hepatocytes did not stain 
with anti-vimentin. However, a light orange-brown granular 
staining was observed in some hepatocytes within neoplas­
tic nodules, which was both intracytoplasraic and 
intranuclear.
b) Factor VUI-r e l a t e d - a n t i g e n  (Factor VIII-RA):
Malignant endothelial cells stained positive, al­
though the intensity of the staining varied greatly. 
Staining appeared as a finely granular cytoplasmic 
dusting to heavy labelling of the entire cytoplasm. Many 
unstained malignant cells were present as well. In larger
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Fig. 3: Positive Factor VIII-RA immunoreactivity (arrow­
heads) HES, lung. SOX
Fig. 4: Positive Factor VIII-RA immunoreactivity (arrow­
heads) HES, lung. 50X
cells with abundant cytoplasm, staining was often local- - 
ized peripherally. The cells that labeled most heavily 
were often those lining vascular spaces, however, 
individual cells or cellular groups also stained within 
more solid regions of the neoplasms. Normal blood vessel 
endothelium usually exhibited strong immunoreactivity for 
Factor VIII-RA in all liver sections.
c) Desmin:
The overwhelming majority of malignant cells did not 
stain positively for desmin. However, small, spindleloid 
cells admixed with the larger, more anaplastic cells did 
occasionally show positive staining. In one HES, there 
were quite a few endothelial cells which lined the vascu­
lar space and stained strongly positive for desmin (Fig.
4).
d) Cytokeratin:
Malignant endothelial tumors were uniformly negative 
for both cytokeratin products used (BioGenex, Triton).
II. Altered foci, Adenomas/Carcinomas
Normal hepatocytes, altered foci, dysplastic hepato- 
cytes, neoplastic nodules and early hepatocellular carci­
nomas did not stain specifically for cytokeratin, vimen- 
tin, desmin, or Factor V U I - r e l a t e d - a n t i g e n .
III. Benign tumors of bile duct origin
Bile duct epithelium did stain positively for cyto­
keratin with the BioGenex, but not the Triton product.
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With the BioGenex product, the staining intensity varied, 
with focal, heavy labelling usually apical or perinuclear 
in location (Fig. 13). Altered biliary ductular structures 
incorporated into the fibrosis associated with endothelial 
neoplasms tended to stain more uniformly heavy. Epitheli­
al cells lining ductules within simple and cystic cholan- 
gioma, and areas of cholangiofibrosis, all stained moder­
ately to strongly positive. Biliary duct epithelium, both 
normal and altered, was negative for Factor V U I - r e l a t e d -  
antigen, vimentin, and desmin.
Renal Neoplasms
I. Renal Mesenchymal Tumors
a) Vimentin:
Positive labelling of individual mesenchymal spindle 
cells was observed in all tumors examined. In most cells 
that stained, the positive staining was localized toward 
one p o l e  of the cell, and was rather w a v y  in a p p e a r a n c e  
(Fig. 9). Filaments occuring as spherical cytoplasmic 
aggregates did not occur as in the hepatic endothelial 
sarcomas. Delicate fibrillary staining patterns tended to 
surround basilar regions of renal tubules incorporated by 
neoplastic processes. In fact, it appeared that some of 
the incorporated tubular epithelial cells expressed 
positive vimentin staining in focal areas along the basi­
lar region of the cell. Positive vimentin staining was
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Fig. 5: Positive cytokeratin immunoreactivity in tubules 
and neoplastic cells (arrowheads). Carcinoma, 
kidney
Fig. 6: Focal immunoreactivity for vimentin (arrowheads)
Carcinoma, kidney. 50X
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also noted within cells forming vascular spaces and in 
cells lining the blood-filled channels seen in the one RMT 
with an exclusively vascular differentiation (Fig. 10). In 
no RMT was there heavy labelling of the majority of spin­
dle cells. Normal rat glomerular cellular components which 
stained regularly were the podocytes, endothelial cells of 
glomerular capillaries and mesangial cells. Occasional 
spindle cells within the interstitium would also label 
positively with vimentin.
b) Factor V U I - r e l a t e d - a n t i g e n :
Most RMTs had neoplastic cells which stained positive 
for Factor VIII-RA, although staining intensity varied a- 
mong the tumors examined. In the largest RMT, staining was 
essentially negative. Perhaps several cells throughout the 
entire s e c t ion,and these were lining v a s c u l a r  spaces, 
contained a fine to moderate cytoplasmic dusting. In the 
other spindleloid RMT, positive staining was fairly in­
tense in spindle cells lining definitive vascular spaces 
or in small groups of spindle cells which gave the impres­
sion of attempting to form vessels (Fig. 8). Staining re­
vealed more clearly the fusiform nature of the RMT cells. 
Endothelial cells lining the blood-filled spaces and 
channels in the one RMT with a purely vascular differ­
entiation stained positive for Factor VIII-RA (Fig. 11). 
Normal areas of kidney exhibited positive staining of 
glomerular tuft endothelial cells as well as vascular en-
161
Fig. 7: Positive cytokeratin immunoreactivity, sequestered 
tubules, RMT. 20X
Fig. 8: Positive Factor VIII—RA immunoreactivity (arrow­
heads), RMT. 20X
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dothellura throughout the kidney.
c) Desmin:
Only a few spindle cells labelled positively. These 
included spindle cells in sheet-like as well as vascular 
arrangements. Staining appeared as wavy segments toward 
one cellular pole or as small, spherical, dot-like for­
mations within the cytoplasm. No cells within the vascu­
lar RMT stained positively with desmin. Within the nor­
mal rat glomerulus, staining intensity for desmin varied 
greatly from one glomerulus to another. In those with 
strong desmin staining,the staining was localized primari­
ly in podocytes and mesangial cells.
d) Cytokeratin:
RMT cells did not exhibit positive staining. However, 
sequestered renal tubules within RMTs often exhibited 
strong positive staining (Fig. 7). This staining was 
observed only when using the BioGenex cytokeratin product. 
With the Triton cytokeratin cocktail sequestered tubular 
epithelial cells were uniformly negative.
II. Renal Adenomas/Carcinomas
a) Cytokeratin:
Most neoplastic epithelial cells were negative for 
cytokeratin using both cytokeratin products. However, with 
the BioGenex product there was focal light to moderate 
staining within neoplastic cells forming solid trabecu-
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Fig. 9: Focal positive vimentin immunoreactivity (arrow­
heads), spindle cells, RMT. 50X
Fig.10: Positive vimentin immunoreactivity (arrowheads), 
RMT (hemangiosarcomatous variant). 20X
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lae, often adjacent to the tumor border (Fig. 5). This 
staining appeared to be localized to the apical and later­
al cell borders. Renal tubular epithelium in cortical 
tissue compressed by the expanding carcinomas stained 
strongly positive with BioGenex cytokeratin (Fig. 5).
In normal sections of rat kidney only distal convoluted 
tubular epithelium and urothelium stained strongly po­
sitive for cytokeratin (Again, only the BioGenex product 
successfully stained rat epithelium)
b) Vimentin:
Most neoplastic cells did not stain positively for 
vimentin. On close inspection, however, isolated tumor 
cells had focal dark-staining aggregates within the cyto­
plasm (Fig. 6). This focal positive staining varied in its 
location in the cytoplasm, being located apically, basal- 
ly, or adjacent to the nucleus. Some spindle-shaped 
stromal cells and endothelial cells were also viraentin- 
positive.
c) Factor V U I - r e l a t e d - a n t i g e n :
Only vascular endothelial cells stained for Factor
f
VIII-RA within the renal epithelial tumors.
d) Desmin:
No positive staining for desmin was seen within 
renal epithelial neoplasms.
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Areas of alveolar cell hyperplasia and pulmonary a- 
denomas did not stain positive for cytokeratin with the 
products used (BioGenex,Triton). Within the carcinomas, 
certain individual cells or small groups of cells usually 
corresponding to areas of squamous metaplasia did stain 
moderately positive for cytokeratin (BioGenex). Cells ad­
jacent to metaplastic areas would also exhibit staining, 
usually in an apical or subapical location within the 
cell. No cytokeratin staining was observed in normal rat 
pulmonary epithelial cells (BioGenex,Tr i t o n ) .
b) Vimentin:
Only vascular endothelial cells within pulmonary tu­
mors stained positive for vimentin.
c) Factor Vlll-related-antigen:
Only vascular endothelial cells within pulmonary tu­
mors stained positive with Factor VIII-RA.
d) Desmin:
No hyperplastic or neoplastic epithelial cells 
stained positive for desmin.
II. Metastatic Hemangioendothelial Sarcomas
a) Vimentin, Factor V U I - r e l a t e d - a n t i g e n :
Staining of metastatic cells was identical to malig-
Fig.13: Positive cytokeratin immunoreactivity (arrowheads) 
cholangiofibrosis, liver. Note that hepatocytes 
are unstained. 20X
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nant endothelial cells in the primary liver tumors (Figs. 
2,3). Not all metastatic foci stained with equal intensity 
and some intracapillary metastatic foci consisting of only 
a few cells did not stain positively at all. Also, for a 
particular endothelial tumor examined, vimentin positivi- 
ty was observed in fewer cells in the metastatic sites 
(Fig. 2) as compared to the primary tumor (Fig.l),
b) Desmin:
An occasional spindle-shaped cell within the metasta­
tic masses would stain positive for desmin. These were 
found in the larger m e t a s t a s e s  which formed d e f i n i t i v e  
vascular spaces.
c) Cytokeratin:
No metastatic HES cells stained positive for cytoker­
atin (BioGenex,Triton).
Alcohol and Acetone-Fixed Liver and Kidney:
These tissue sections did not stain appreciably bet­
ter than formalin-fixed sections. In fact, most of the 
staining was of a nonspecific nature. The degree of 
cellular distortion observed in sections made these 
particular fixation techniques highly undesirable as 
compared to 10% NBF.
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DISCUSSION
Use of commercial immunohistocheraical products on 
forma1 in-fixed,paraffin-embedded tissues of the rat 
proved to be of value in augmenting and reconfirming the 
earlier gross, microscopic, and ultrastructural findings 
of this carcinogenesis study on DMN-induced tumors.
Varying numbers of neoplastic cells within hemangio- 
endothelial sarcomas labelled strongly with both vimentin 
and Factor VIII-RA. Identical staining patterns were re­
tained with metastasis. The localization of vimentin fila­
ments within HES cells has been previously reported using 
immunofluorescence and electron microscopy (22). The pre­
sent study confirms this, as well as indicating that many 
anaplastic endothelial cells become cytoplasmically "en­
gorged" with vimentin filaments. This excess of vimentin 
filaments within tumor cells has been speculated to be 
the result of a defect in cellular metabolism, perhaps 
similar to the metabolic abnormalities seen in carcinogen- 
induced, preneoplastic hepatocytes (10).
The fact that HES cells produce Factor VIII-RA fur­
ther corroborates their endothelial origin (115). Whether 
nonhemangiovascular endothelium can produce significant 
quantities of Factor VIII-RA is still controversial. 
Lymphatic endothelial cells have been reported to produce 
Factor VIII-RA but in small quantities (116); malignant 
endothelial cells in the present study often exhibited
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solid cytoplasmic staining with Factor VIII-RA. Also, the 
HES cellular arrangements to form or line vascular spaces 
was not compatible with tumors of lymphatic endothelial 
origin.
Desmin staining of some HES cells was an interest­
ing finding. It probably represents the normal heteroge­
neity within a population of anaplastic mesenchymal cells 
reflecting different degrees of differentiation or dif­
ferent lines of differentiation resulting in subpopula­
tions of neoplastic cells which exhibit specific func­
tional attributes. This is not merely dedifferentiation, 
in which case the presence of cytokeratins in neoplastic 
mesenchymal cells would more reasonably be expected (81).
Spindle cells in the RMTs exhibited staining patterns 
which varied from tumor to tumor. That this neoplastic 
derivative of the resident cortical fibrocyte should be 
able to express Factor VIII-RA, vimentin, and occasional­
ly desmin is not surprising considering the heterogeneity 
of tissue types into which it is c a p a b l e  of 
differentiating (42,43). In fact, the expression of 
particular IFs or other cell products is most likely a 
reflection of a specific function within the neoplasm. 
Thus, those neoplastic spindle cells capable of forming 
vascular spaces or clefts stained strongly positive for 
Factor VIII-RA. Spindle cells forming whorl-like patterns 
around sequestered tubules sometimes contained bundles of
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vimentin filaments. Previous ultrastructural descriptions 
of these tumors suggested morphological variations in 
subpopulations of neoplastic cells, and specifically 
pointed out the resemblance of spindle cells surrounding 
sequestered tubules to smooth muscle cells (43). Such 
spindle cells in the present study did not express desmin, 
as would be expected for cells of the smooth muscle type.
Within the normal kidney interstitium, a spindle- 
shaped cell stained positive for vimentin. However, a 
recent study by Stamenkovic et al described a similar cell 
type as desmin positive and vimentin negative (118), This 
same study described a similar pattern of desmin staining 
within the rat glomerulus as seen in the present study 
(118). However, desmin reactivity in rat glomerular tufts 
observed in the present report was not of uniform 
intensity among glomeruli. Perhaps this reflects 
differences due to fixation as Stamenkovic et al used 
frozen sections for immunohistocheraica1 staining (118).
The one RMT with a vascular predominance expressed 
cellular antigens identical to endothelial cells. This 
may present a diagnostic dilemma, or at least a dilemma 
in terminology; what should one call this particular 
tumor? The most recent suggestion is a hemangio­
sarcomatous variant of RMT (39). This appears satisfacto­
ry if one assumes that all hemangiosarcomatous neoplasms 
in the kidney indeed represent a vascular differentiation
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of the carcinogen-induced cortical fibrocyte. It doesn't 
take into account the possible complicating factor that 
such "variants" arise de novo from mature endothelium in 
the kidney. One also has to consider the implications of 
whether this theory of a multipotential mesenchymal cell 
might not apply to extrarenal systems. Could not a heman- 
gioendothelial sarcoma arise from a similar cell, as yet 
unidentified, within the liver?
Neoplastic prestages and neoplasms derived from epi­
thelial cells in the liver, kidney, and lung presented 
other interpretation problems.
In the liver, no hepatocytic foci or hepatic neo­
plasms labelled definitively and repeatedly positive with 
any of the cytokeratin products used. The MAK-6 cytokera­
tin cocktail (Triton) contains a monoclonal antibody which 
should specifically react with the two primary types of 
hepatocytic cytokeratins found in humans (81) and theore­
tically might have labelled rat hepatocytes. The poly­
clonal cytokeratin (BioGenex) contained antibodies 
primarily against two cytokeratin polypeptides found 
primarily within squamous epithelial cells. The BioGenex 
product specifically labelled bile duct epithelia and 
benign tumors derived from bile duct epithelia. Similar 
staining results have been seen in human livers using 
antibodies to human epidermal keratin from the stratum 
corneum of the foot (119,120). Based on the results
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obtained in this study, it appears that the BioGenex 
polyclonal cytokeratin can be used to differentiate tumors 
derived from hepatocytes from those of biliary epithelial 
origin. Although no malignant biliary tumors were observed 
in this study, a previous immunofluorescence study 
reported the staining intensity of normal bile duct 
epithelia and cholangiocellular carcinoma cells to be very 
similar (121), which suggests that cholangiocarcinoraas, 
had they arisen, might have stained positively with this 
cytokeratin product.
In the kidney, the BioGenex polyclonal cytokeratin 
specifically labelled epithelial cells of collecting 
ducts and urothelium. This is in agreement with what has 
previuosly stained in the human kidney with antibodies a- 
gainst epidermal keratin (119). However, human renal car­
cinomas derived from proximal tubular epithelium have been 
successfully labelled using antibodies prepared against 
cytokeratin polypeptides of 41, 45, 48, and 56kD isolated 
from canine and porcine renal epithelial cells (122,123). 
Interestingly, many of the same renal carcinomas 
coexpressed vimentin (122).
The BioGenex cytokeratin product contains antibodies 
against a 56kD cytokeratin polypeptide, and the Triton 
product contains antibodies which recognize cytokeratin 
polypeptides of 48 and 45kD, among others. Based on this 
information it is conceivable that both products should
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have labelled proximal tubular epithelia and probably 
their resultant carcinomas, unless the 41kD or other cy­
tokeratin polypeptides are the predominant ones in rat 
proximal tubular epithelial cells.
The BioGenex cytokeratin did focally label some 
carcinoma cells along the tumor border, which brings 
up an interesting point about the cytokeratin labelling 
seen in this study. The most uniform, heavy staining was 
noted in sequestered or compressed tubules either as a 
result of RMT infiltration, disruptive fibrosis associ­
ated with hemangioendothelial sarcomas, or from compres­
sion due to an adjacent expanding tumor. In the RMT, Hard 
et al (43) have described u 1 trastructura1 changes in 
sequestered epithelial cells which coincide with a more 
primitive, less-differentiated, less-specialized 
epithelial cell type. Perhaps this loss of specialization 
also results in changes in cytokeratin polypeptide 
composition within these cells, which somehow increases 
the staining intensity, either through the appearance of 
new cytokeratins which label optimally with the particular 
cytokeratin products used or the increased production of 
cytokeratin polypeptides produced minimally previously.
In the pulmonary tumors, the BioGenex product 
stained only cells within carcinomas associated with 
squamous metaplasia. Human epidermal keratin antibodies 
label only basal cells, intermediate cells and ducts of
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the submucosal glands In normal human lung. Of human 
pulmonary neoplasms, only the squamous cell carcinoma 
labels strongly positive (120). In the rat, no epithelial 
cell in the normal lung labelled positively with either 
cytokeratin product. The status of cytokeratin polypep­
tides in normal or neoplastic type II pneumocytes is 
currently unknown.
In summary, the BioGenex polyclonal cytokeratin la­
belled rat epithelia in a similar manner as do antibodies 
against epidermal keratin in the human (119). The Triton 
monoclonal cytokeratin was uniformly unsuccessful in la­
belling cytokeratins in rat epithelial cells.
The reasons for this at the present time are purely 
speculative. It may be that the monoclonal antibodies 
which react with various human cytokeratin polypeptides 
in fact do not cross-react with rat cytokeratin polypep­
tides. This seems unlikely, as cytokeratins are a family 
of proteins that are highly conserved during evolution and 
show marked immunologic cross-reactivity in different spe­
cies and in different tissues (121). The difference among 
species may lie, however, in the distribution of specific 
cytokeratin polypeptides within different epithelial tis­
sues (121). It is possible that there are significant 
differences, just as there are probably striking similar­
ities, in the distribution of cytokeratin polypeptides 
between the rat and man. Some minor but significant
differences in cytokeratin polypeptide patterns have 
been noted between rat and human liver (121).
An alternative explanation is the possible effect of 
f o r m a l i n  fixation,Perhaps c ertain c y t o k e r a t i n  p o l y p e p ­
tides are more sensitive to formalin denaturization or 
are more effectively "masked" by formalin than are others.
At any rate, since the catalog of human cytokeratins 
is so extensive, and it is not unreasonable to assume that 
this applies to most, if not all, mammalian species, then 
it appears that the task of differentiating epithelial-de­
rived tumors from each other will lie in determining the 
precise cytokeratin polypeptide composition of all epi­
thelial cell types in the normal animal species of inter­
est.
Despite the sensitivity of the avidin-biotin tech­
nique there are a multitude of technical difficulties that 
need to be surmounted before reliable results can be 
obtained. Such technical considerations briefly include: 
the choice of primary antibodies from a reliable company, 
the necessity of trypsinizat;,ion using porcine-derived 
trypsin on formalin-fixed specimens (124), and nonspecific 
background staining, which may be the result of high 
concentrations of "ABC" in the reagents used or due to the 
amount of tissue necrosis present in the particular sec­
tions (117).
Perhaps the most important concluding point of this
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discussion section is the problem of interpretation-that 
is, when is the immunohistochemical staining specific and 
real? This is often subject to the interpreter's experience 
and unfortunately, perhaps,‘the interpreter’s often less 
than objective point of view.
Recent applications of IF localization in various 
neoplasms may eventually shatter the 'maxims’ established 
for IFs several years ago (79,125). The rule that tumors 
only contain the IF type(s) present in the cells of ori­
gin is presently being challenged (125). Even in this ex­
periment there were unexpected nuances of IF expression: 
i.e. the expression of vimentin in some renal 
adenocarcinoma cells and the desmin filaments seen in 
some HES cells. Despite the absence of such positive 
staining in identical negative control sections, the 
question remains as to whether one is one to attribute 
this 'aberrant' staining to a manifestation of a 
nonspecific staining pattern, or as an unimportant fluke 
of nature which occasionally occurs but should be ignored. 
Should IF staining be of "picture-book" quality before it 
should be considered as positive, or should tumor 
characterization also take into account the IF expression 
of a small minority of neoplastic cells which do not 
necessarily express the 'expected' IF type(s)?
Very few tumors in this study stained with the uni­
form intensity as those observed in the photographs sup-
plied in the various manufacturers' catalogs. But the 
nature of the particular staining observed in the various 
tumor types may eventually reveal more about the histogen­
esis of the respective tumors, or about the nature of ma­
lignancy, then had the staining been unequivocally what 
was expected.
CHAPTER V 
SUMMARY AND CONCLUSIONS 
Now is the time one wishes for a deus ex machina to 
intervene and sort out the tangled webs of this study.
DMN, the product of aminopyrine and nitrite in the acidic 
environment of the rat stomach (7), successfully induced 
neoplasms in three target organ systems; namely, the liver, 
kidneys, and lungs. In the liver and kidneys, induced neo­
plasms were derived from both epithelial and mesenchymal 
cells, whereas in the lung only epithelial-derived tumors 
were induced with DMN. The site of metabolism of DMN to 
the ultimate carcinogen is not known with certainty in the 
lung, but it appears that the alveolar type II pneumocyte 
is perhaps the exclusive target cell in this organ. In 
the kidney and liver, the target cells include the epi­
thelial cells which metabolize the compound, as well as 
adjacent mesenchymal cells (i.e. endothelium, cortical f i- 
brocyte) which are susceptible to the toxic effects of 
the metabolites (100).
The effects of metabolic manipulations on the num­
ber and location of various tumor types was in some cases 
particularly obvious, such as the marked hepatoprotective 
influences of phenobarbital and ethanol, and in other 
cases rather disappointing. AAN did not significantly 
protect the liver epithelium from carcinogen-induced da­
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mage, but may have altered hepatic DMN metabolism enough 
t o a l l o w  significant extrahepatic metabolism ofDMN. At 
any rate, future users of AAN as a DMN-demethylase inhi­
bitor may be more successful utilizing a higher dosage 
or more frequent dose schedule.
In Chapter III, an assay was used to determine the 
specific activity of P-A50 dependent, hepatic 0-demethyl- 
ase enzyme. This did not reveal any startling information 
except that 0-demethylase activity is influenced in the 
same manner as many P-A50 dependent enzyme systems by 
such inducers as phenobarbital and ethanol. This is in op­
position to what is known about DMN-demethylase, and to 
essentially what was observed in this study where the 
typical inducers failed to increase tumor yield in the 
primary target organ, but alternatively protected against 
tumor formation. The mechanism of this protection, whether 
through actual inhibition of the enzyme system, stimula­
tion of detoxification pathways, or induction of alterna­
tive metabolic pathways is not discernible from this 
study, but the occurrance of extrahepatic neoplasms is 
s u g g e s t i v e  of a direct i n h i b i t i v e  m e c h a n i s m  on hepatic 
DMN-demethylase.
Iramunohistochemical staining of the various DMN-in- 
duced neoplasms was generally successful in confirming 
their histogenesis. Several commercial primary antibody 
products and avidin-biotin kits were employed. Some tu-
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mor types, such as hemangioendothelial sarcomas, stained 
with repeated reliability with both vimentin and Factor 
VIII RA, including pulmonary metastatic sites, confirming 
their vascular origin. Renal mesenchymal tumors were ra­
ther a ’mixed bag', as expected from their proposed origin 
from a multipotential mesenchymal cell, but also displayed 
vasoformative tendencies as confirmed by the Factor VIII 
RA immunoreactivity seen in various neoplastic cells.
Staining of the cytokeratins followed patterns al­
most identical to those seen in studies in normal and neo­
plastic human tissues labelled with antibodies against 
keratin from human foot sole stratum corneum (119,120). 
Positive immunoreactivity to cytokeratins was thus limited 
to collecting ducts in the kidney, sequestered renal 
tubules in RMT's, areas of squamous metaplasia in 
pulmonary carcinomas, and proliferating bile ducts or 
benign biliary neoplasms. Identical cytokeratin products 
did not label cytokeratins present in hepatocytes, 
proximal convoluted tubular (PCT) epithelial cells, and 
lung epithelium. Use of a polyclonal BioGenex cytokeratin 
product indicated that this product could be used in the 
rat liver to potentially differentiate hepatocytic from 
biliary neoplasms. It would be interesting to apply this 
to other species.
The several unexpected staining reactions seen in the 
s t u d y ,a 1 though l imited to a s m a l l  p o p u l a t i o n  of tumor
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cells, raises certain questions of the future applica­
tion in differentiating tumors on the basis of their IF 
composition. A recent study which localized four types of 
IFs within neoplastic cells of a pulmonary neoplasm dis­
turbingly echoes these fears (125).
Immunocytochemistry may prove of more value in the 
future understanding of neoplastic transformation or may 
be useful in characterizing certain cellular subpopula­
tions within a particular neoplasm. The utilization of 
cellular products such as oncodevelopmental proteins (126) 
could be helpful, in conjuction with IF composition, in 
characterizing tumor cells. For instance, proximal con- 
vuluted tubular epithelial cells in the canine are strong­
ly immunoreactive with lysozyme (127). If this were also 
the case for rat PCT epithelia, then lysozyme could 
potentially be used as a reliable marker for carcinomas 
derived from PCT epithelium in the rat kidney, provided 
that such malignantly transformed epithelial cells 
continued to express lysozyme.
The evolving complexity of what various cells do or
t
do not express upon malignant transformation is worthy of 
further research, keeping in mind that there may be much 
intra as well as interspecies variation. The tenets esta­
blished a few short years ago for IF expression are not 
as immutable as once thought, but this needn't totally ne­
gate their diagnostic and research potential.
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